| (+)-artemisinin | increases expression | ISO | RGD:10451 | 6480464 | artemisinine results in increased expression of CYP2E1 mRNA | CTD | PMID:17962186 |
| (+)-taxifolin | decreases expression | ISO | RGD:1345007 | 6480464 | taxifolin results in decreased expression of CYP2E1 mRNA | CTD | PMID:17541156 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:10451 | 6480464 | epigallocatechin gallate results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:14600287 |
| (-)-epigallocatechin 3-gallate | affects binding | EXP | | 6480464 | epigallocatechin gallate binds to CYP2E1 protein | CTD | PMID:23010222 |
| (R)-carnitine | multiple interactions | EXP | | 6480464 | Carnitine promotes the reaction [Ethanol results in increased expression of CYP2E1 protein] | CTD | PMID:8130774 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of CYP2E1 protein | CTD | PMID:16434548 |
| 1,1-dichloroethene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of vinylidene chloride | CTD | PMID:15319346 PMID:10215634 |
| 1,1-dichloroethene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of vinylidene chloride | CTD | PMID:10215634 PMID:15319346 |
| 1,1-dichloroethene | increases metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased metabolism of vinylidene chloride | CTD | PMID:11356946 PMID:15319346 |
| 1,1-dichloroethene | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of vinylidene chloride | CTD | PMID:15319346 |
| 1,1-dichloroethene | multiple interactions | ISO | RGD:1345007 | 6480464 | diallyl sulfone inhibits the reaction [CYP2E1 protein results in increased metabolism of vinylidene chloride] | CTD | PMID:10215634 |
| 1,2,3,5-tetrachlorobenzene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 1,2,3,5-tetrachlorobenzene | CTD | PMID:7747284 |
| 1,2,3,5-tetrachlorobenzene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 1,2,3,5-tetrachlorobenzene | CTD | PMID:7747284 |
| 1,2,4,5-tetrachlorobenzene | increases expression | EXP | | 6480464 | 1,2,4,5-tetrachlorobenzene results in increased expression of CYP2E1 protein | CTD | PMID:10696772 |
| 1,2,4-trichlorobenzene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 1,2,4-trichlorobenzene | CTD | PMID:7747284 |
| 1,2,4-trichlorobenzene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 1,2,4-trichlorobenzene | CTD | PMID:7747284 |
| 1,2-dibromoethane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Ethylene Dibromide | CTD | PMID:18350910 PMID:10841534 |
| 1,2-dibromoethane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Ethylene Dibromide | CTD | PMID:10841534 PMID:18350910 |
| 1,2-dichlorobenzene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 2-dichlorobenzene | CTD | PMID:9817075 PMID:7747284 |
| 1,2-dichlorobenzene | multiple interactions | EXP | | 6480464 | [Benzene results in increased activity of CYP2E1 protein] which results in increased metabolism of 2-dichlorobenzene; more ... | CTD | PMID:9817075 |
| 1,2-dichlorobenzene | increases oxidation | EXP | | 6480464 | CYP2E1 protein results in increased oxidation of 2-dichlorobenzene | CTD | PMID:9817075 |
| 1,2-dichlorobenzene | multiple interactions | ISO | RGD:10451 | 6480464 | dihydroxyethyldithiocarbamate inhibits the reaction [[Benzene results in increased activity of CYP2E1 protein] which results in increased metabolism of 2-dichlorobenzene] | CTD | PMID:9817075 |
| 1,2-dichlorobenzene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 2-dichlorobenzene | CTD | PMID:7747284 |
| 1,2-dichlorobenzene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 2-dichlorobenzene | CTD | PMID:7747284 PMID:9817075 |
| 1,2-dichloroethene | multiple interactions | EXP | | 6480464 | 1,2-dichloroethylene inhibits the reaction [CYP2E1 protein affects the metabolism of Trichloroethylene]; more ... | CTD | PMID:7871537 |
| 1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:15205388 more ... |
| 1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:9344893 more ... |
| 1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:20127315 more ... |
| 1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:15205388 more ... |
| 1,2-dichloroethene | decreases expression | EXP | | 6480464 | 1,2-dichloroethylene results in decreased expression of CYP2E1 protein | CTD | PMID:9671540 |
| 1,2-dichloroethene | multiple interactions | EXP | | 6480464 | 1,2-dichloroethylene inhibits the reaction [Acetone results in increased activity of CYP2E1 protein] | CTD | PMID:9851676 |
| 1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:9671540 more ... |
| 1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:9671540 more ... |
| 1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:20127315 more ... |
| 1,2-dichloroethene | multiple interactions | ISO | RGD:10451 | 6480464 | 1,2-dichloroethylene inhibits the reaction [CYP2E1 protein results in increased oxidation of 1,3-butadiene] | CTD | PMID:10828257 |
| 1,4-dichlorobenzene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 4-dichlorobenzene | CTD | PMID:7747284 |
| 1,4-dichlorobenzene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 4-dichlorobenzene | CTD | PMID:9817075 PMID:7747284 |
| 1,4-dichlorobenzene | multiple interactions | EXP | | 6480464 | [Isoniazid results in increased activity of CYP2E1 protein] which results in increased metabolism of 4-dichlorobenzene | CTD | PMID:9051121 |
| 1,4-dichlorobenzene | increases expression | EXP | | 6480464 | 4-dichlorobenzene results in increased expression of CYP2E1 protein | CTD | PMID:10696772 |
| 1,4-dichlorobenzene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 4-dichlorobenzene | CTD | PMID:7747284 PMID:9817075 |
| 1,4-dioxane | multiple interactions | EXP | | 6480464 | 1,4-dioxane results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:15490126 |
| 1,4-dioxane | increases expression | EXP | | 6480464 | 1,4-dioxane results in increased expression of CYP2E1 mRNA | CTD | PMID:15490126 |
| 1,4-dioxane | increases activity | EXP | | 6480464 | 1,4-dioxane results in increased activity of CYP2E1 protein | CTD | PMID:15490126 |
| 1,4-naphthoquinone | increases abundance | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased abundance of 1,4-naphthoquinone | CTD | PMID:16243959 |
| 1-naphthol | increases abundance | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased abundance of 1-naphthol | CTD | PMID:16243959 |
| 1-naphthyl isothiocyanate | decreases expression | ISO | RGD:10451 | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of CYP2E1 mRNA | CTD | PMID:15913567 |
| 17beta-estradiol | decreases expression | ISO | RGD:1345007 | 6480464 | Estradiol results in decreased expression of CYP2E1 mRNA | CTD | PMID:20106945 |
| 19(S)-HETE | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of 19-hydroxy-5,8,11,14-eicosatetraenoic acid | CTD | PMID:15205388 |
| 19-HETE | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of 19-hydroxy-5,8,11,14-eicosatetraenoic acid | CTD | PMID:15205388 |
| 1H-imidazole | increases expression | EXP | | 6480464 | imidazole results in increased expression of CYP2E1 protein | CTD | PMID:3337723 |
| 1H-pyrazole | increases expression | ISO | RGD:1345007 | 6480464 | pyrazole results in increased expression of CYP2E1 protein | CTD | PMID:8074729 |
| 1H-pyrazole | increases expression | EXP | | 6480464 | pyrazole results in increased expression of CYP2E1 protein | CTD | PMID:3113478 more ... |
| 1H-pyrazole | increases expression | EXP | | 6480464 | pyrazole results in increased expression of CYP2E1 protein | CTD | PMID:3113478 more ... |
| 1H-pyrazole | increases activity | EXP | | 6480464 | pyrazole results in increased activity of CYP2E1 protein | CTD | PMID:3782137 PMID:8734847 |
| 1H-pyrazole | increases expression | EXP | | 6480464 | pyrazole results in increased expression of CYP2E1 protein | CTD | PMID:8734847 more ... |
| 1H-pyrazole | increases expression | EXP | | 6480464 | pyrazole results in increased expression of CYP2E1 protein | CTD | PMID:3782137 more ... |
| 1H-pyrazole | increases activity | EXP | | 6480464 | pyrazole results in increased activity of CYP2E1 protein | CTD | PMID:8734847 PMID:3782137 |
| 1H-pyrazole | increases expression | EXP | | 6480464 | pyrazole results in increased expression of CYP2E1 protein | CTD | PMID:8734847 more ... |
| 1H-pyrazole | affects expression | ISO | RGD:10451 | 6480464 | pyrazole affects the expression of CYP2E1 protein | CTD | PMID:19679878 |
| 1H-pyrazole | increases expression | ISO | RGD:10451 | 6480464 | pyrazole results in increased expression of CYP2E1 protein | CTD | PMID:9698299 |
| 2,3,5,6-tetrachlorophenol | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 2,3,5,6-tetrachlorophenate | CTD | PMID:7747284 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1345007 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2E1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2E1 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1345007 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYP2E1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1345007 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2E1 mRNA | CTD | PMID:20106945 PMID:21296121 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2E1 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1345007 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2E1 mRNA | CTD | PMID:21296121 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2E1 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2E1 mRNA | CTD | PMID:19692669 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10451 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2E1 mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10451 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP2E1 mRNA | CTD | PMID:16120747 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP2E1 mRNA | CTD | PMID:19969063 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in decreased expression of CYP2E1 mRNA | CTD | PMID:21602191 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2E1 mRNA | CTD | PMID:16054898 PMID:18796159 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10451 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYP2E1 mRNA | CTD | PMID:17949056 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP2E1 protein | CTD | PMID:18079364 |
| 2,6-dimethylaniline | multiple interactions | ISO | RGD:1345007 | 6480464 | fomepizole inhibits the reaction [CYP2E1 protein affects the metabolism of 2,6-xylidine metabolite] | CTD | PMID:11409937 |
| 2,6-dimethylaniline | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of 2,6-xylidine metabolite | CTD | PMID:11409937 |
| 2,6-dimethylnaphthalene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 2,6-dimethylnaphthalene | CTD | PMID:17156750 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of CYP2E1 protein; more ... | CTD | PMID:15916741 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CYP2E1 protein | CTD | PMID:17393424 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP2E1 mRNA | CTD | PMID:14656948 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP2E1 mRNA | CTD | PMID:16158176 |
| 2-naphthol | increases abundance | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased abundance of 2-naphthol | CTD | PMID:16243959 |
| 2-nitroanisole | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 2-nitroanisole | CTD | PMID:15144223 |
| 2-nitroanisole | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 2-nitroanisole | CTD | PMID:17159769 PMID:21218109 |
| 2-nitroanisole | increases oxidation | EXP | | 6480464 | CYP2E1 protein results in increased oxidation of 2-nitroanisole | CTD | PMID:21218109 |
| 2-nitroanisole | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 2-nitroanisole | CTD | PMID:21218109 PMID:17159769 |
| 2-nitrophenol | increases oxidation | EXP | | 6480464 | CYP2E1 protein results in increased oxidation of 2-nitrophenol | CTD | PMID:20027144 |
| 2-nitrophenol | affects chemical synthesis | EXP | | 6480464 | CYP2E1 protein affects the chemical synthesis of 2-nitrophenol | CTD | PMID:11409192 |
| 2-nitrophenol | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 2-nitrophenol | CTD | PMID:17159769 |
| 2-nitrophenol | affects chemical synthesis | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the chemical synthesis of 2-nitrophenol | CTD | PMID:11409192 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CYP2E1 mRNA | CTD | PMID:19692669 |
| 3,3',5-triiodo-L-thyronine | increases activity | EXP | | 6480464 | Triiodothyronine results in increased activity of CYP2E1 protein | CTD | PMID:14631868 |
| 3,3',5-triiodo-L-thyronine | increases expression | EXP | | 6480464 | Triiodothyronine results in increased expression of CYP2E1 protein | CTD | PMID:14631868 |
| 3,4-dihydroxybenzoic acid | multiple interactions | EXP | | 6480464 | [protocatechuic acid co-treated with Methylcholanthrene] results in decreased activity of CYP2E1 protein | CTD | PMID:15302093 |
| 3,4-dihydroxybenzoic acid | decreases activity | EXP | | 6480464 | protocatechuic acid results in decreased activity of CYP2E1 protein | CTD | PMID:15302093 |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | [Acetone co-treated with Methylcholanthrene] results in decreased expression of CYP2E1 mRNA; more ... | CTD | PMID:8734847 |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP2E1 protein | CTD | PMID:10476907 PMID:19889059 |
| 3-methylcholanthrene | decreases expression | EXP | | 6480464 | Methylcholanthrene results in decreased expression of CYP2E1 protein | CTD | PMID:8734847 PMID:3113478 |
| 3-methylcholanthrene | decreases expression | EXP | | 6480464 | Methylcholanthrene results in decreased expression of CYP2E1 mRNA | CTD | PMID:7493548 PMID:8734847 |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | [protocatechuic acid co-treated with Methylcholanthrene] results in decreased activity of CYP2E1 protein | CTD | PMID:15302093 |
| 3-methylcholanthrene | decreases expression | EXP | | 6480464 | Methylcholanthrene results in decreased expression of CYP2E1 mRNA | CTD | PMID:8734847 PMID:7493548 |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP2E1 mRNA; more ... | CTD | PMID:19889059 |
| 3-methylcholanthrene | decreases expression | EXP | | 6480464 | Methylcholanthrene results in decreased expression of CYP2E1 protein | CTD | PMID:3113478 PMID:8734847 |
| 3-methylcholanthrene | decreases activity | EXP | | 6480464 | Methylcholanthrene results in decreased activity of CYP2E1 protein | CTD | PMID:8734847 |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | Methylcholanthrene promotes the reaction [CYP2E1 protein results in increased oxidation of Toluene] | CTD | PMID:1994898 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CTD | PMID:12920169 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CTD | PMID:12115524 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases activity | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of CYP2E1 protein | CTD | PMID:9774145 |
| 4-nitrophenol | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 4-nitrophenol | CTD | PMID:12464242 more ... |
| 4-nitrophenol | increases hydroxylation | EXP | | 6480464 | CYP2E1 protein results in increased hydroxylation of 4-nitrophenol | CTD | PMID:11408273 more ... |
| 4-nitrophenol | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 4-nitrophenol | CTD | PMID:10207612 more ... |
| 4-nitrophenol | increases hydroxylation | EXP | | 6480464 | CYP2E1 protein results in increased hydroxylation of 4-nitrophenol | CTD | PMID:9065729 more ... |
| 4-nitrophenol | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 4-nitrophenol | CTD | PMID:15576447 more ... |
| 4-nitrophenol | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 4-nitrophenol | CTD | PMID:9143349 more ... |
| 4-nitrophenol | increases hydroxylation | EXP | | 6480464 | CYP2E1 protein results in increased hydroxylation of 4-nitrophenol | CTD | PMID:8267643 more ... |
| 4-nitrophenol | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 4-nitrophenol | CTD | PMID:9825833 more ... |
| 4-nitrophenol | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of 4-nitrophenol | CTD | PMID:14669323 more ... |
| 4-nitrophenol | increases hydroxylation | EXP | | 6480464 | CYP2E1 protein results in increased hydroxylation of 4-nitrophenol | CTD | PMID:9065729 more ... |
| 4-nitrophenol | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 4-nitrophenol | CTD | PMID:8531136 more ... |
| 4-nitrophenol | multiple interactions | EXP | | 6480464 | S-Adenosylmethionine inhibits the reaction [CYP2E1 protein results in increased metabolism of 4-nitrophenol] | CTD | PMID:15763544 |
| 4-nitrophenol | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of 4-nitrophenol | CTD | PMID:7601153 PMID:15763544 |
| 4-nitrophenol | multiple interactions | EXP | | 6480464 | Ditiocarb inhibits the reaction [CYP2E1 protein results in increased hydroxylation of 4-nitrophenol]; more ... | CTD | PMID:9618253 |
| 4-nitrophenol | multiple interactions | EXP | | 6480464 | Chlormethiazole inhibits the reaction [CYP2E1 protein results in increased metabolism of 4-nitrophenol]; more ... | CTD | PMID:7601153 |
| 4-nitrophenol | increases hydroxylation | EXP | | 6480464 | CYP2E1 protein results in increased hydroxylation of 4-nitrophenol | CTD | PMID:11408273 more ... |
| 4-nitrophenol | multiple interactions | EXP | | 6480464 | allyl sulfide inhibits the reaction [CYP2E1 protein results in increased metabolism of 4-nitrophenol] | CTD | PMID:7601153 PMID:8117321 |
| 4-nitrophenol | multiple interactions | EXP | | 6480464 | Acetone promotes the reaction [CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] | CTD | PMID:8267643 |
| 4-nitrophenol | multiple interactions | EXP | | 6480464 | 2-(allylthio)pyrazine inhibits the reaction [CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] | CTD | PMID:9065729 |
| 4-nitrophenol | multiple interactions | EXP | | 6480464 | 4-nitrophenol inhibits the reaction [CYP2E1 protein results in increased metabolism of methylformamide] | CTD | PMID:1538706 |
| 4-nitrophenol | increases hydroxylation | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased hydroxylation of 4-nitrophenol | CTD | PMID:10094576 PMID:15742976 |
| 4-nitrophenol | multiple interactions | ISO | RGD:1345007 | 6480464 | Tetradecanoylphorbol Acetate promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol]; more ... | CTD | PMID:8531136 PMID:9143349 |
| 4-nitrophenol | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 4-nitrophenol | CTD | PMID:10207612 more ... |
| 4-nitrophenol | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of 4-nitrophenol | CTD | PMID:15135088 more ... |
| 4-nitrophenol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] | CTD | PMID:8531136 PMID:8074729 |
| 4-nitrophenol | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 4-nitrophenol | CTD | PMID:12464242 more ... |
| 4-nitrophenol | multiple interactions | ISO | RGD:1345007 | 6480464 | Cycloheximide inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol]] | CTD | PMID:9143349 |
| 4-nitrophenol | multiple interactions | ISO | RGD:1345007 | 6480464 | Bucladesine promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol]; more ... | CTD | PMID:8531136 |
| 4-nitrophenol | multiple interactions | ISO | RGD:1345007 | 6480464 | 4-nitrophenol inhibits the reaction [CYP2E1 protein results in increased metabolism of Theobromine] | CTD | PMID:10215755 |
| 4-nitrophenol | multiple interactions | ISO | RGD:1345007 | 6480464 | Carbon Tetrachloride inhibits the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol]; more ... | CTD | PMID:9143349 PMID:8531136 |
| 4-nitrophenol | multiple interactions | ISO | RGD:1345007 | 6480464 | 4-nitrophenol inhibits the reaction [CYP2E1 protein results in increased oxidation of norflurane] | CTD | PMID:1356728 |
| 4-nitrophenol | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 4-nitrophenol | CTD | PMID:11212141 more ... |
| 4-nitrophenol | increases hydroxylation | EXP | | 6480464 | CYP2E1 protein results in increased hydroxylation of 4-nitrophenol | CTD | PMID:11911841 more ... |
| 4-nitrophenol | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 4-nitrophenol | CTD | PMID:9825833 more ... |
| 4-nitrophenol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] | CTD | PMID:8074729 PMID:8531136 |
| 4-nitrophenol | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 4-nitrophenol | CTD | PMID:10207612 more ... |
| 4-nitrophenol | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of 4-nitrophenol | CTD | PMID:14669323 more ... |
| 4-nitrophenol | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of 4-nitrophenol | CTD | PMID:15763544 PMID:7601153 |
| 4-nitrophenol | multiple interactions | EXP | | 6480464 | allyl sulfide inhibits the reaction [CYP2E1 protein results in increased metabolism of 4-nitrophenol] | CTD | PMID:8117321 PMID:7601153 |
| 4-nitrophenol | increases hydroxylation | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased hydroxylation of 4-nitrophenol | CTD | PMID:15742976 PMID:10094576 |
| 4-vinylcyclohexene dioxide | affects response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the susceptibility to 4-vinyl-1-cyclohexene dioxide | CTD | PMID:18622027 |
| 7,12-dimethyltetraphene | affects response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene | CTD | PMID:18622027 |
| 7-ethoxycoumarin | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 7-ethoxycoumarin | CTD | PMID:18385292 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:1345007 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP2E1 mRNA | CTD | PMID:22079614 |
| acarbose | decreases expression | EXP | | 6480464 | Acarbose results in decreased expression of CYP2E1 mRNA | CTD | PMID:14975757 |
| acephate | multiple interactions | ISO | RGD:10451 | 6480464 | [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP2E1 protein; more ... | CTD | PMID:17686559 |
| acetaldehyde | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Acetaldehyde | CTD | PMID:10826103 |
| acetaldehyde | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 protein results in increased metabolism of Ethanol] which results in increased abundance of Acetaldehyde | CTD | PMID:18845238 |
| acetaldehyde | multiple interactions | EXP | | 6480464 | [CYP2E1 protein results in increased metabolism of Ethanol] which results in increased chemical synthesis of Acetaldehyde; more ... | CTD | PMID:7562599 |
| acetic acid | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Acetic Acid analog | CTD | PMID:21933969 |
| acetone | increases expression | EXP | | 6480464 | Acetone results in increased expression of CYP2E1 protein | CTD | PMID:8267643 more ... |
| acetone | increases expression | EXP | | 6480464 | Acetone results in increased expression of CYP2E1 mRNA | CTD | PMID:11939710 more ... |
| acetone | increases activity | EXP | | 6480464 | Acetone results in increased activity of CYP2E1 protein | CTD | PMID:12919724 more ... |
| acetone | increases expression | EXP | | 6480464 | Acetone results in increased expression of CYP2E1 protein | CTD | PMID:11939710 more ... |
| acetone | increases expression | EXP | | 6480464 | Acetone results in increased expression of CYP2E1 protein | CTD | PMID:12919724 more ... |
| acetone | increases activity | EXP | | 6480464 | Acetone results in increased activity of CYP2E1 protein | CTD | PMID:12919724 more ... |
| acetone | increases expression | EXP | | 6480464 | Acetone results in increased expression of CYP2E1 protein | CTD | PMID:8267643 more ... |
| acetone | increases activity | EXP | | 6480464 | Acetone results in increased activity of CYP2E1 protein | CTD | PMID:12919724 more ... |
| acetone | increases expression | EXP | | 6480464 | Acetone results in increased expression of CYP2E1 mRNA | CTD | PMID:2241968 more ... |
| acetone | increases expression | EXP | | 6480464 | Acetone results in increased expression of CYP2E1 protein | CTD | PMID:1968335 more ... |
| acetone | increases activity | EXP | | 6480464 | Acetone results in increased activity of CYP2E1 protein | CTD | PMID:9851676 more ... |
| acetone | increases expression | EXP | | 6480464 | Acetone results in increased expression of CYP2E1 protein | CTD | PMID:11939710 more ... |
| acetone | increases activity | EXP | | 6480464 | Acetone results in increased activity of CYP2E1 protein | CTD | PMID:12919724 more ... |
| acetone | multiple interactions | ISO | RGD:10451 | 6480464 | [Acetone results in increased expression of CYP2E1 protein] which results in increased susceptibility to allyl cyanide | CTD | PMID:18990727 |
| acetone | increases expression | ISO | RGD:10451 | 6480464 | Acetone results in increased expression of CYP2E1 protein | CTD | PMID:18990727 |
| acetone | increases expression | EXP | | 6480464 | Acetone results in increased expression of CYP2E1 protein | CTD | PMID:15763544 more ... |
| acetone | increases expression | EXP | | 6480464 | Acetone results in increased expression of CYP2E1 mRNA | CTD | PMID:11939710 more ... |
| acetone | increases activity | EXP | | 6480464 | Acetone results in increased activity of CYP2E1 protein | CTD | PMID:3782137 more ... |
| acetone | multiple interactions | EXP | | 6480464 | Acetone promotes the reaction [CYP2E1 protein results in increased hydroxylation of 4-nitrophenol] | CTD | PMID:8267643 |
| acetone | multiple interactions | EXP | | 6480464 | Acetone promotes the reaction [2-xylene results in increased expression of CYP2E1 protein]; more ... | CTD | PMID:8996725 |
| acetone | multiple interactions | EXP | | 6480464 | [Acetone co-treated with Methylcholanthrene] results in decreased expression of CYP2E1 mRNA; more ... | CTD | PMID:8734847 |
| acetone | multiple interactions | EXP | | 6480464 | [Acetone co-treated with ciprofibrate] results in increased expression of CYP2E1 protein | CTD | PMID:7587954 |
| acetone | multiple interactions | EXP | | 6480464 | 1,2-dichloroethylene inhibits the reaction [Acetone results in increased activity of CYP2E1 protein]; more ... | CTD | PMID:9851676 |
| acetone | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Acetone | CTD | PMID:15576447 |
| acetone | multiple interactions | ISO | RGD:10451 | 6480464 | Acetone results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:8013281 |
| acetone | increases activity | EXP | | 6480464 | Acetone results in increased activity of CYP2E1 protein | CTD | PMID:8734847 more ... |
| acetonitrile | multiple interactions | EXP | | 6480464 | acetonitrile inhibits the reaction [CYP2E1 protein results in increased metabolism of 7-methoxy-4-trifluoromethylcoumarin] | CTD | PMID:19858067 |
| acetonitrile | multiple interactions | ISO | RGD:1345007 | 6480464 | acetonitrile inhibits the reaction [Cycloheximide results in increased degradation of CYP2E1 protein] | CTD | PMID:9143349 |
| acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of CYP2E1 mRNA | CTD | PMID:11752103 |
| acrylamide | affects expression | ISO | RGD:1345007 | 6480464 | Acrylamide affects the expression of CYP2E1 mRNA | CTD | PMID:17267090 |
| acrylamide | increases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased susceptibility to Acrylamide | CTD | PMID:17267090 PMID:15355880 |
| acrylamide | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 gene polymorphism co-treated with GSTM1 gene polymorphism] affects the metabolism of Acrylamide; more ... | CTD | PMID:19131562 |
| acrylamide | increases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased susceptibility to Acrylamide | CTD | PMID:15355880 PMID:17267090 |
| acrylamide | increases oxidation | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased oxidation of Acrylamide | CTD | PMID:15355880 |
| acrylamide | affects metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the metabolism of Acrylamide | CTD | PMID:17979661 |
| acrylonitrile | affects response to substance | EXP | | 6480464 | CYP2E1 protein affects the susceptibility to Acrylonitrile | CTD | PMID:20127315 |
| aflatoxin B1 | affects expression | ISO | RGD:1345007 | 6480464 | Aflatoxin B1 affects the expression of CYP2E1 protein | CTD | PMID:20106945 |
| aflatoxin B1 | decreases expression | ISO | RGD:1345007 | 6480464 | Aflatoxin B1 results in decreased expression of CYP2E1 mRNA | CTD | PMID:22100608 |
| aflatoxin B1 | decreases expression | ISO | RGD:10451 | 6480464 | Aflatoxin B1 results in decreased expression of CYP2E1 mRNA | CTD | PMID:19770486 |
| alizarin | decreases activity | ISO | RGD:1345007 | 6480464 | alizarin results in decreased activity of CYP2E1 protein | CTD | PMID:12379470 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1345007 | 6480464 | Tretinoin promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] | CTD | PMID:8531136 |
| allyl alcohol | increases expression | ISO | RGD:10451 | 6480464 | allyl alcohol results in increased expression of CYP2E1 protein | CTD | PMID:11515535 |
| alpha-hexachlorocyclohexane | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP2E1 protein | CTD | PMID:16246485 |
| alpha-linolenic acid | decreases activity | ISO | RGD:1345007 | 6480464 | alpha-Linolenic Acid results in decreased activity of CYP2E1 protein | CTD | PMID:16978661 |
| amitrole | decreases activity | ISO | RGD:1345007 | 6480464 | Amitrole results in decreased activity of CYP2E1 protein | CTD | PMID:12464242 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CYP2E1 mRNA | CTD | PMID:16483693 |
| angelicin | decreases expression | ISO | RGD:10451 | 6480464 | angelicin results in decreased expression of CYP2E1 protein | CTD | PMID:22173200 |
| aniline | decreases activity | ISO | RGD:1345007 | 6480464 | aniline results in decreased activity of CYP2E1 protein | CTD | PMID:12814958 PMID:15306208 |
| aniline | increases hydroxylation | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased hydroxylation of aniline | CTD | PMID:18038910 more ... |
| aniline | increases hydroxylation | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased hydroxylation of aniline | CTD | PMID:18038910 more ... |
| aniline | increases hydroxylation | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased hydroxylation of aniline | CTD | PMID:18436364 more ... |
| aniline | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of aniline | CTD | PMID:8819299 PMID:12464242 |
| aniline | increases hydroxylation | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased hydroxylation of aniline | CTD | PMID:18291569 more ... |
| aniline | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of aniline | CTD | PMID:9195021 PMID:8858968 |
| aniline | decreases activity | ISO | RGD:1345007 | 6480464 | aniline results in decreased activity of CYP2E1 protein | CTD | PMID:15306208 PMID:12814958 |
| aniline | multiple interactions | EXP | | 6480464 | [Grape Seed Proanthocyanidins results in decreased activity of CYP2E1 protein] which results in decreased hydroxylation of aniline | CTD | PMID:11330834 |
| aniline | multiple interactions | EXP | | 6480464 | allyl sulfide inhibits the reaction [CYP2E1 protein results in increased metabolism of aniline] | CTD | PMID:8117321 |
| aniline | increases hydroxylation | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased hydroxylation of aniline | CTD | PMID:18291569 more ... |
| aniline | multiple interactions | ISO | RGD:10451 | 6480464 | puerarin inhibits the reaction [CYP2E1 protein results in increased hydroxylation of aniline] | CTD | PMID:18038910 |
| aniline | multiple interactions | ISO | RGD:10451 | 6480464 | Changkil inhibits the reaction [CYP2E1 protein results in increased hydroxylation of aniline] | CTD | PMID:18291569 |
| aniline | multiple interactions | ISO | RGD:10451 | 6480464 | phenyl caffeate inhibits the reaction [CYP2E1 protein results in increased hydroxylation of aniline] | CTD | PMID:18436364 |
| aniline | multiple interactions | ISO | RGD:1345007 | 6480464 | Proadifen inhibits the reaction [CYP2E1 protein results in increased metabolism of aniline] | CTD | PMID:8819299 |
| aniline | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of aniline | CTD | PMID:12464242 PMID:8819299 |
| aniline | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol promotes the reaction [CYP2E1 protein results in increased oxidation of aniline] | CTD | PMID:8074729 |
| aniline | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of [norharman co-treated with aniline] | CTD | PMID:15279827 |
| aniline | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of aniline | CTD | PMID:8858968 PMID:9195021 |
| arachidonic acid | multiple interactions | ISO | RGD:1345007 | 6480464 | allyl sulfide inhibits the reaction [CYP2E1 protein results in increased susceptibility to [ferric nitrilotriacetate co-treated with Arachidonic Acid]]; more ... | CTD | PMID:12086689 |
| arachidonic acid | decreases activity | ISO | RGD:1345007 | 6480464 | Arachidonic Acid results in decreased activity of CYP2E1 protein | CTD | PMID:16978661 |
| arachidonic acid | affects hydroxylation | EXP | | 6480464 | CYP2E1 protein affects the hydroxylation of Arachidonic Acid | CTD | PMID:15205388 |
| arachidonic acid | multiple interactions | ISO | RGD:1345007 | 6480464 | [Arachidonic Acid co-treated with ferric nitrilotriacetate co-treated with Ethanol] results in increased expression of CYP2E1 protein; more ... | CTD | PMID:17034788 |
| arachidonic acid | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 results in increased susceptibility to Arachidonic Acid | CTD | PMID:12566070 |
| arachidonic acid | multiple interactions | ISO | RGD:1345007 | 6480464 | Cadmium Chloride affects the reaction [CYP2E1 protein results in increased susceptibility to Arachidonic Acid]; more ... | CTD | PMID:12566070 |
| Aroclor 1254 | decreases expression | ISO | RGD:1345007 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP2E1 mRNA | CTD | PMID:17851650 |
| Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP2E1 protein | CTD | PMID:3113478 |
| Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP2E1 mRNA | CTD | PMID:8471063 |
| arsenic atom | affects expression | ISO | RGD:1345007 | 6480464 | Arsenic affects the expression of CYP2E1 mRNA | CTD | PMID:18414638 |
| arsenic atom | decreases activity | EXP | | 6480464 | Arsenic results in decreased activity of CYP2E1 protein | CTD | PMID:19932728 |
| arsenic atom | multiple interactions | EXP | | 6480464 | Arsenic inhibits the reaction [Acetaminophen results in increased activity of CYP2E1 protein] | CTD | PMID:19932728 |
| aspartame | multiple interactions | EXP | | 6480464 | Aspartame results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:16937917 |
| benzene | increases activity | EXP | | 6480464 | Benzene results in increased activity of CYP2E1 protein | CTD | PMID:12919724 more ... |
| benzene | multiple interactions | ISO | RGD:10451 | 6480464 | [Toluene co-treated with Benzene] results in increased activity of CYP2E1 protein | CTD | PMID:18455711 |
| benzene | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of Benzene | CTD | PMID:15122651 PMID:20033806 |
| benzene | increases expression | ISO | RGD:1345007 | 6480464 | Benzene results in increased expression of CYP2E1 mRNA | CTD | PMID:18952161 |
| benzene | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein alternative form results in increased hydroxylation of Benzene | CTD | PMID:20033806 |
| benzene | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to Benzene | CTD | PMID:15226677 more ... |
| benzene | increases hydroxylation | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased hydroxylation of Benzene | CTD | PMID:14718178 PMID:11718959 |
| benzene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Benzene | CTD | PMID:18350910 more ... |
| benzene | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to Benzene | CTD | PMID:17095285 more ... |
| benzene | increases activity | EXP | | 6480464 | Benzene results in increased activity of CYP2E1 protein | CTD | PMID:12919724 more ... |
| benzene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Benzene | CTD | PMID:9817075 more ... |
| benzene | increases activity | EXP | | 6480464 | Benzene results in increased activity of CYP2E1 protein | CTD | PMID:20338863 more ... |
| benzene | increases expression | ISO | RGD:10451 | 6480464 | Benzene results in increased expression of CYP2E1 mRNA | CTD | PMID:17157166 PMID:12928149 |
| benzene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of Benzene | CTD | PMID:10207612 PMID:9817075 |
| benzene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Benzene | CTD | PMID:18350910 more ... |
| benzene | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to Benzene | CTD | PMID:15226677 more ... |
| benzene | multiple interactions | EXP | | 6480464 | Progesterone promotes the reaction [Benzene results in decreased activity of CYP2E1 protein] | CTD | PMID:18407866 |
| benzene | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Benzene results in increased activity of CYP2E1 protein] | CTD | PMID:20338863 |
| benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of CYP2E1 protein; more ... | CTD | PMID:12919724 |
| benzene | multiple interactions | EXP | | 6480464 | [Benzene results in increased activity of CYP2E1 protein] which results in increased metabolism of 2-dichlorobenzene; more ... | CTD | PMID:9817075 |
| benzene | increases activity | EXP | | 6480464 | Benzene results in increased activity of CYP2E1 protein | CTD | PMID:20338863 more ... |
| benzene | decreases expression | EXP | | 6480464 | Benzene results in decreased expression of CYP2E1 protein | CTD | PMID:15274493 |
| benzene | affects expression | EXP | | 6480464 | Benzene affects the expression of CYP2E1 mRNA | CTD | PMID:15878777 |
| benzene | decreases activity | EXP | | 6480464 | Benzene results in decreased activity of CYP2E1 protein | CTD | PMID:18407866 |
| benzene | multiple interactions | EXP | | 6480464 | Benzene promotes the reaction [CYP2E1 protein results in increased metabolism of Methylene Chloride] | CTD | PMID:8889796 |
| benzene | multiple interactions | ISO | RGD:10451 | 6480464 | [Benzene results in increased activity of CYP2E1 protein] which results in increased metabolism of 2-dichlorobenzene; more ... | CTD | PMID:9817075 |
| benzene | increases hydroxylation | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased hydroxylation of Benzene | CTD | PMID:11718959 PMID:14718178 |
| benzene | increases metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased metabolism of Benzene | CTD | PMID:11376689 |
| benzene | increases expression | ISO | RGD:10451 | 6480464 | Benzene results in increased expression of CYP2E1 protein | CTD | PMID:12388843 |
| benzene | increases expression | ISO | RGD:10451 | 6480464 | Benzene results in increased expression of CYP2E1 mRNA | CTD | PMID:12928149 PMID:17157166 |
| benzene | multiple interactions | ISO | RGD:10451 | 6480464 | AHR protein affects the reaction [Benzene results in increased expression of CYP2E1 protein] | CTD | PMID:12388843 |
| benzene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of Benzene | CTD | PMID:9817075 PMID:10207612 |
| benzene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Benzene | CTD | PMID:17885617 more ... |
| benzene | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of Benzene | CTD | PMID:15122651 |
| benzene | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the susceptibility to Benzene | CTD | PMID:12460800 |
| benzene | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism results in increased susceptibility to Benzene | CTD | PMID:15226677 |
| benzene | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Benzene | CTD | PMID:15226677 |
| benzene | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to Benzene | CTD | PMID:16737589 more ... |
| benzene | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to Benzene | CTD | PMID:16737589 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CYP2E1 mRNA; more ... | CTD | PMID:19889059 |
| benzo[a]pyrene | increases expression | ISO | RGD:1345007 | 6480464 | Benzo(a)pyrene results in increased expression of CYP2E1 mRNA | CTD | PMID:16269432 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CYP2E1 mRNA; more ... | CTD | PMID:19889059 PMID:21383588 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10451 | 6480464 | Benzo(a)pyrene results in decreased expression of CYP2E1 mRNA | CTD | PMID:19770486 PMID:20127859 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10451 | 6480464 | Benzo(a)pyrene results in decreased expression of CYP2E1 mRNA | CTD | PMID:20127859 PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10451 | 6480464 | Benzo(a)pyrene results in decreased expression of CYP2E1 mRNA | CTD | PMID:20127859 |
| benzo[b]fluoranthene | increases expression | ISO | RGD:1345007 | 6480464 | benzo(b)fluoranthene results in increased expression of CYP2E1 mRNA | CTD | PMID:16269432 |
| benzylideneacetone | increases oxidation | EXP | | 6480464 | CYP2E1 protein results in increased oxidation of benzylideneacetone | CTD | PMID:15863696 |
| berberine | decreases expression | ISO | RGD:10451 | 6480464 | Berberine results in decreased expression of CYP2E1 mRNA | CTD | PMID:22342832 |
| berberine | multiple interactions | ISO | RGD:10451 | 6480464 | Berberine inhibits the reaction [Isoniazid results in increased expression of CYP2E1 mRNA] | CTD | PMID:22342832 |
| beta-carboline | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of [norharman co-treated with aniline] | CTD | PMID:15279827 |
| bilobalide | increases activity | EXP | | 6480464 | bilobalide results in increased activity of CYP2E1 protein | CTD | PMID:18421621 |
| biotin | multiple interactions | ISO | RGD:1345007 | 6480464 | Biotin inhibits the reaction [Cycloheximide results in increased degradation of CYP2E1 protein] | CTD | PMID:9143349 |
| bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of CYP2E1 protein | CTD | PMID:10547960 |
| bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of CYP2E1 mRNA | CTD | PMID:12628495 |
| bromodichloromethane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of bromodichloromethane | CTD | PMID:18350910 more ... |
| bromodichloromethane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of bromodichloromethane | CTD | PMID:12076522 more ... |
| bromodichloromethane | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of bromodichloromethane | CTD | PMID:11295256 PMID:12076521 |
| bromodichloromethane | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of bromodichloromethane | CTD | PMID:12076521 PMID:11295256 |
| bromodichloromethane | increases expression | EXP | | 6480464 | bromodichloromethane results in increased expression of CYP2E1 protein | CTD | PMID:11295256 |
| bromodichloromethane | multiple interactions | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of and results in increased activity of bromodichloromethane | CTD | PMID:9458004 |
| bromodichloromethane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of bromodichloromethane | CTD | PMID:18350910 more ... |
| bromodichloromethane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of bromodichloromethane | CTD | PMID:12076522 more ... |
| bromodichloromethane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of bromodichloromethane | CTD | PMID:12076521 more ... |
| bucladesine | multiple interactions | ISO | RGD:1345007 | 6480464 | Bucladesine promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] | CTD | PMID:8531136 |
| buta-1,3-diene | multiple interactions | ISO | RGD:10451 | 6480464 | 1,2-dichloroethylene inhibits the reaction [CYP2E1 protein results in increased oxidation of 1,3-butadiene]; more ... | CTD | PMID:10828257 |
| buta-1,3-diene | increases oxidation | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased oxidation of 1,3-butadiene | CTD | PMID:10828257 |
| buta-1,3-diene | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of 1,3-butadiene | CTD | PMID:15470755 |
| butan-2-one | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene mutant form affects the susceptibility to methylethyl ketone | CTD | PMID:21352904 |
| butane-1,3-diol | increases activity | EXP | | 6480464 | 1,3-butylene glycol results in increased activity of CYP2E1 protein | CTD | PMID:2919394 |
| butane-1,3-diol | increases expression | EXP | | 6480464 | 1,3-butylene glycol results in increased expression of CYP2E1 protein | CTD | PMID:2919394 |
| C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of CYP2E1 mRNA | CTD | PMID:19167457 |
| cadmium dichloride | decreases expression | ISO | RGD:10451 | 6480464 | Cadmium Chloride results in decreased expression of CYP2E1 mRNA | CTD | PMID:11958953 |
| cadmium dichloride | multiple interactions | ISO | RGD:1345007 | 6480464 | Cadmium Chloride affects the reaction [CYP2E1 protein results in increased susceptibility to Arachidonic Acid] | CTD | PMID:12566070 |
| caffeine | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Caffeine | CTD | PMID:14586387 PMID:1302044 |
| caffeine | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Caffeine | CTD | PMID:1302044 PMID:14586387 |
| caffeine | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Caffeine | CTD | PMID:14586387 |
| calcium atom | affects expression | EXP | | 6480464 | Calcium affects the expression of CYP2E1 mRNA | CTD | PMID:15913539 |
| calcium atom | decreases uptake | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in decreased uptake of Calcium | CTD | PMID:19028543 |
| calcium(0) | affects expression | EXP | | 6480464 | Calcium affects the expression of CYP2E1 mRNA | CTD | PMID:15913539 |
| calcium(0) | decreases uptake | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in decreased uptake of Calcium | CTD | PMID:19028543 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of CYP2E1 | CTD | PMID:22375877 |
| carbamazepine | decreases expression | EXP | | 6480464 | Carbamazepine results in decreased expression of CYP2E1 mRNA | CTD | PMID:17381134 |
| carnosine | multiple interactions | ISO | RGD:10451 | 6480464 | Carnosine inhibits the reaction [Acetaminophen results in increased activity of CYP2E1 protein] | CTD | PMID:19799668 |
| chlorobenzene | multiple interactions | ISO | RGD:1345007 | 6480464 | dihydroxyethyldithiocarbamate inhibits the reaction [CYP2E1 protein results in increased metabolism of chlorobenzene] | CTD | PMID:9817075 |
| chlorobenzene | increases oxidation | EXP | | 6480464 | CYP2E1 protein results in increased oxidation of chlorobenzene | CTD | PMID:9817075 |
| chlorobenzene | multiple interactions | EXP | | 6480464 | [Benzene results in increased activity of CYP2E1 protein] which results in increased metabolism of chlorobenzene; more ... | CTD | PMID:9817075 |
| chlorobenzene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of chlorobenzene | CTD | PMID:9817075 |
| chloroethene | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism promotes the reaction [Vinyl Chloride affects the mutagenesis of KRAS gene]; more ... | CTD | PMID:12705718 |
| chloroethene | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to Vinyl Chloride | CTD | PMID:20134343 |
| chloroethene | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of Vinyl Chloride | CTD | PMID:7871537 PMID:17710613 |
| chloroethene | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene SNP results in increased susceptibility to Vinyl Chloride | CTD | PMID:18420361 PMID:20100738 |
| chloroethene | increases activity | EXP | | 6480464 | Vinyl Chloride results in increased activity of CYP2E1 protein | CTD | PMID:15211785 PMID:17710613 |
| chloroethene | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism promotes the reaction [Vinyl Chloride results in increased mutagenesis of TP53 gene] | CTD | PMID:17384900 PMID:12010862 |
| chloroethene | increases activity | EXP | | 6480464 | Vinyl Chloride results in increased activity of CYP2E1 protein | CTD | PMID:17710613 PMID:15211785 |
| chloroethene | multiple interactions | EXP | | 6480464 | 1,2-dichloroethylene inhibits the reaction [CYP2E1 protein affects the metabolism of Vinyl Chloride] | CTD | PMID:7871537 |
| chloroethene | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of Vinyl Chloride | CTD | PMID:17710613 PMID:7871537 |
| chloroethene | increases activity | ISO | RGD:1345007 | 6480464 | Vinyl Chloride results in increased activity of CYP2E1 protein | CTD | PMID:17710613 |
| chloroethene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Vinyl Chloride | CTD | PMID:18350910 |
| chloroethene | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Vinyl Chloride | CTD | PMID:17710613 |
| chloroethene | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene SNP results in increased susceptibility to Vinyl Chloride | CTD | PMID:20100738 PMID:18420361 |
| chloroethene | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism results in increased susceptibility to Vinyl Chloride | CTD | PMID:16270392 |
| chloroethene | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism promotes the reaction [Vinyl Chloride results in increased mutagenesis of TP53 gene] | CTD | PMID:12010862 PMID:17384900 |
| chloroethene | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism promotes the reaction [Vinyl Chloride results in increased mutagenesis of KRAS gene] | CTD | PMID:17384900 |
| chloroform | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Chloroform | CTD | PMID:18350910 |
| chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of CYP2E1 mRNA | CTD | PMID:23125180 |
| chlorpromazine | decreases activity | ISO | RGD:1345007 | 6480464 | Chlorpromazine results in decreased activity of CYP2E1 protein | CTD | PMID:15135088 |
| chlorzoxazone | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Chlorzoxazone | CTD | PMID:12818727 more ... |
| chlorzoxazone | increases hydroxylation | EXP | | 6480464 | CYP2E1 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:11911841 more ... |
| chlorzoxazone | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Chlorzoxazone | CTD | PMID:12401345 more ... |
| chlorzoxazone | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:12433797 more ... |
| chlorzoxazone | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Chlorzoxazone | CTD | PMID:12818727 more ... |
| chlorzoxazone | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Chlorzoxazone | CTD | PMID:16124035 more ... |
| chlorzoxazone | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:8558417 more ... |
| chlorzoxazone | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of Chlorzoxazone | CTD | PMID:15879494 PMID:15231049 |
| chlorzoxazone | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:8858968 more ... |
| chlorzoxazone | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Chlorzoxazone | CTD | PMID:12464242 more ... |
| chlorzoxazone | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Chlorzoxazone | CTD | PMID:12818727 more ... |
| chlorzoxazone | multiple interactions | EXP | | 6480464 | Imidazoles inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone]; more ... | CTD | PMID:21600194 |
| chlorzoxazone | increases hydroxylation | EXP | | 6480464 | CYP2E1 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:21600194 more ... |
| chlorzoxazone | multiple interactions | ISO | RGD:1345007 | 6480464 | perfluorooctane sulfonic acid inhibits the reaction [CYP2E1 protein results in increased oxidation of Chlorzoxazone] | CTD | PMID:21964418 |
| chlorzoxazone | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Chlorzoxazone | CTD | PMID:9825833 more ... |
| chlorzoxazone | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of Chlorzoxazone | CTD | PMID:10207612 PMID:21964418 |
| chlorzoxazone | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:15255802 more ... |
| chlorzoxazone | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Chlorzoxazone | CTD | PMID:15327588 more ... |
| chlorzoxazone | increases hydroxylation | EXP | | 6480464 | CYP2E1 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:21600194 more ... |
| chlorzoxazone | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:15618748 more ... |
| chlorzoxazone | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Chlorzoxazone | CTD | PMID:12401345 more ... |
| chlorzoxazone | increases hydroxylation | EXP | | 6480464 | CYP2E1 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:11911841 PMID:15205388 |
| chlorzoxazone | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of Chlorzoxazone | CTD | PMID:15231049 PMID:15879494 |
| chlorzoxazone | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Chlorzoxazone | CTD | PMID:15576447 more ... |
| chlorzoxazone | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:15802389 more ... |
| chlorzoxazone | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of Chlorzoxazone | CTD | PMID:10207612 |
| chlorzoxazone | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Chlorzoxazone | CTD | PMID:15327588 more ... |
| chlorzoxazone | multiple interactions | ISO | RGD:1345007 | 6480464 | CYB5 protein promotes the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone] | CTD | PMID:15728263 |
| chlorzoxazone | multiple interactions | ISO | RGD:1345007 | 6480464 | [Chlorzoxazone results in decreased activity of CYP2E1 protein] which results in decreased degradation of vanoxerine | CTD | PMID:11502731 |
| chlorzoxazone | affects hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the hydroxylation of Chlorzoxazone | CTD | PMID:7747284 |
| chlorzoxazone | increases hydroxylation | EXP | | 6480464 | CYP2E1 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:15205388 more ... |
| chlorzoxazone | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of Chlorzoxazone | CTD | PMID:21964418 PMID:10207612 |
| chlorzoxazone | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Chlorzoxazone | CTD | PMID:12464242 more ... |
| chlorzoxazone | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:8858968 more ... |
| cholesterol | decreases activity | ISO | RGD:10451 | 6480464 | Cholesterol results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| choline | multiple interactions | EXP | | 6480464 | Choline deficiency promotes the reaction [Acetaminophen results in increased expression of CYP2E1 protein]; more ... | CTD | PMID:18798224 |
| choline | multiple interactions | ISO | RGD:10451 | 6480464 | [Methionine deficiency co-treated with Choline deficiency] results in increased activity of CYP2E1 protein; more ... | CTD | PMID:18952117 |
| choline | multiple interactions | ISO | RGD:10451 | 6480464 | [Betaine co-treated with Choline co-treated with Folic Acid co-treated with Methionine co-treated with Vitamin B 12 co-treated with Zinc Sulfate] inhibits the reaction [Ethanol results in increased expression of CYP2E1 protein] | CTD | PMID:20118189 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:10451 | 6480464 | Ciguatoxins affects the expression of CYP2E1 mRNA | CTD | PMID:18353800 |
| cimetidine | multiple interactions | ISO | RGD:1345007 | 6480464 | [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP2E1 protein | CTD | PMID:22733800 |
| cimetidine | decreases expression | ISO | RGD:1345007 | 6480464 | Cimetidine results in decreased expression of CYP2E1 protein | CTD | PMID:22733800 |
| cinnamic acid | decreases activity | ISO | RGD:1345007 | 6480464 | cinnamic acid analog results in decreased activity of CYP2E1 protein | CTD | PMID:15072549 |
| ciprofibrate | multiple interactions | EXP | | 6480464 | [Acetone co-treated with ciprofibrate] results in increased expression of CYP2E1 protein; more ... | CTD | PMID:7587954 |
| ciprofibrate | increases expression | EXP | | 6480464 | ciprofibrate results in increased expression of CYP2E1 mRNA | CTD | PMID:7587954 |
| cis-caffeic acid | multiple interactions | EXP | | 6480464 | caffeic acid inhibits the reaction [CYP2E1 protein results in increased reduction of tirapazamine] | CTD | PMID:7710944 |
| cis-ketoconazole | decreases activity | ISO | RGD:1345007 | 6480464 | Ketoconazole results in decreased activity of CYP2E1 protein | CTD | PMID:15618748 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of CYP2E1 mRNA | CTD | PMID:22023808 |
| cisplatin | increases response to substance | EXP | | 6480464 | CYP2E1 protein results in increased susceptibility to Cisplatin | CTD | PMID:20809784 |
| cisplatin | multiple interactions | ISO | RGD:10451 | 6480464 | Cisplatin results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:21616140 |
| clofibrate | multiple interactions | ISO | RGD:10451 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CYP2E1 mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of CYP2E1 mRNA; more ... | CTD | PMID:10476907 |
| copper atom | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 protein co-treated with Copper] results in increased activity of Eugenol | CTD | PMID:15576237 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of CYP2E1 mRNA | CTD | PMID:22465980 |
| copper(0) | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 protein co-treated with Copper] results in increased activity of Eugenol | CTD | PMID:15576237 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of CYP2E1 mRNA | CTD | PMID:22465980 |
| cortisol | increases expression | EXP | | 6480464 | Hydrocortisone results in increased expression of CYP2E1 protein; more ... | CTD | PMID:10476907 |
| curcumin | affects expression | EXP | | 6480464 | Curcumin affects the expression of CYP2E1 protein | CTD | PMID:16805852 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of CYP2E1 mRNA | CTD | PMID:18539377 |
| cyanocob(III)alamin | multiple interactions | ISO | RGD:10451 | 6480464 | [Betaine co-treated with Choline co-treated with Folic Acid co-treated with Methionine co-treated with Vitamin B 12 co-treated with Zinc Sulfate] inhibits the reaction [Ethanol results in increased expression of CYP2E1 protein] | CTD | PMID:20118189 |
| cycloheximide | multiple interactions | ISO | RGD:1345007 | 6480464 | (4-amidinophenyl)methanesulfonyl fluoride inhibits the reaction [Cycloheximide results in increased degradation of CYP2E1 protein]; more ... | CTD | PMID:9143349 |
| cycloheximide | multiple interactions | ISO | RGD:1345007 | 6480464 | Cycloheximide inhibits the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] | CTD | PMID:9143349 PMID:8531136 |
| cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [pyridine results in increased activity of CYP2E1 protein]; more ... | CTD | PMID:1968335 |
| cycloheximide | increases degradation | ISO | RGD:1345007 | 6480464 | Cycloheximide results in increased degradation of CYP2E1 protein | CTD | PMID:9143349 |
| cycloheximide | multiple interactions | ISO | RGD:1345007 | 6480464 | Cycloheximide promotes the reaction [Carbon Tetrachloride results in increased degradation of CYP2E1 protein]; more ... | CTD | PMID:8531136 |
| cycloheximide | multiple interactions | ISO | RGD:1345007 | 6480464 | Cycloheximide inhibits the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] | CTD | PMID:8531136 PMID:9143349 |
| cyclophosphamide | increases metabolic processing | EXP | | 6480464 | CYP2E1 results in increased metabolism of Cyclophosphamide | CTD | PMID:20566340 |
| cyclosporin A | decreases expression | ISO | RGD:1345007 | 6480464 | Cyclosporine results in decreased expression of CYP2E1 mRNA | CTD | PMID:20106945 |
| cypermethrin | increases expression | EXP | | 6480464 | cypermethrin results in increased expression of CYP2E1 mRNA | CTD | PMID:20815782 |
| cypermethrin | decreases activity | ISO | RGD:10451 | 6480464 | cypermethrin results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| daidzein | decreases activity | ISO | RGD:10451 | 6480464 | daidzein results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| deoxycholic acid | multiple interactions | EXP | | 6480464 | Deoxycholic Acid results in decreased expression of and results in decreased activity of CYP2E1 protein; more ... | CTD | PMID:10453939 |
| desferrioxamine B | multiple interactions | EXP | | 6480464 | Deferoxamine inhibits the reaction [CYP2E1 protein results in increased reduction of tirapazamine] | CTD | PMID:7710944 |
| desipramine | decreases activity | ISO | RGD:1345007 | 6480464 | Desipramine results in decreased activity of CYP2E1 protein | CTD | PMID:15135088 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CYP2E1 mRNA | CTD | PMID:14618091 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CYP2E1 mRNA | CTD | PMID:14618091 PMID:20607812 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CYP2E1 mRNA | CTD | PMID:20607812 PMID:14618091 |
| dexamethasone | increases expression | ISO | RGD:10451 | 6480464 | Dexamethasone results in increased expression of CYP2E1 mRNA | CTD | PMID:21041162 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CYP2E1 protein | CTD | PMID:15965953 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of CYP2E1 protein | CTD | PMID:11181506 |
| dextromethorphan | decreases activity | ISO | RGD:10451 | 6480464 | Dextromethorphan results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| diallyl disulfide | decreases expression | ISO | RGD:10451 | 6480464 | diallyl disulfide results in decreased expression of CYP2E1 protein | CTD | PMID:10774820 |
| diallyl disulfide | decreases activity | ISO | RGD:1345007 | 6480464 | diallyl disulfide results in decreased activity of CYP2E1 protein | CTD | PMID:18339364 |
| diallyl disulfide | decreases expression | EXP | | 6480464 | diallyl disulfide results in decreased expression of CYP2E1 protein | CTD | PMID:16000231 |
| diallyl disulfide | multiple interactions | ISO | RGD:10451 | 6480464 | [diallyl disulfide results in decreased expression of CYP2E1 protein] which results in decreased metabolism of and results in decreased susceptibility to Trichloroethylene | CTD | PMID:10774820 |
| diarsenic trioxide | affects expression | ISO | RGD:1345007 | 6480464 | arsenic trioxide affects the expression of CYP2E1 mRNA | CTD | PMID:17530438 |
| diazoxide | affects expression | EXP | | 6480464 | Isoproterenol affects the expression of CYP2E1 mRNA | CTD | PMID:18725507 |
| dibenz[a,h]anthracene | increases expression | ISO | RGD:1345007 | 6480464 | 1,2,5,6-dibenzanthracene results in increased expression of CYP2E1 mRNA | CTD | PMID:16269432 |
| dichloromethane | multiple interactions | EXP | | 6480464 | 3-xylene promotes the reaction [CYP2E1 protein results in increased metabolism of Methylene Chloride]; more ... | CTD | PMID:8889796 |
| dichloromethane | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of Methylene Chloride | CTD | PMID:8889796 |
| dicofol | increases expression | EXP | | 6480464 | Dicofol results in increased expression of CYP2E1 protein | CTD | PMID:19595748 |
| dicoumarol | multiple interactions | EXP | | 6480464 | Dicumarol promotes the reaction [CYP2E1 protein results in increased reduction of tirapazamine] | CTD | PMID:7710944 |
| diepoxybutane | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to erythritol anhydride | CTD | PMID:15036125 |
| diepoxybutane | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism results in increased susceptibility to erythritol anhydride | CTD | PMID:17078101 |
| diethylstilbestrol | increases expression | ISO | RGD:10451 | 6480464 | Diethylstilbestrol results in increased expression of CYP2E1 mRNA | CTD | PMID:21041162 |
| dihydrocapsaicin | increases expression | EXP | | 6480464 | dihydrocapsaicin results in increased expression of CYP2E1 | CTD | PMID:22375877 |
| dimethyl sulfoxide | increases expression | EXP | | 6480464 | Dimethyl Sulfoxide results in increased expression of CYP2E1 protein | CTD | PMID:3113478 |
| dimethyl sulfoxide | multiple interactions | EXP | | 6480464 | Dimethyl Sulfoxide inhibits the reaction [CYP2E1 protein results in increased metabolism of methylformamide] | CTD | PMID:1538706 |
| dimethyl sulfoxide | increases activity | ISO | RGD:10451 | 6480464 | Dimethyl Sulfoxide results in increased activity of CYP2E1 protein | CTD | PMID:17177172 |
| dimethyl sulfoxide | multiple interactions | EXP | | 6480464 | Dimethyl Sulfoxide inhibits the reaction [CYP2E1 protein results in increased metabolism of 7-methoxy-4-trifluoromethylcoumarin] | CTD | PMID:19858067 |
| dimethyl sulfoxide | multiple interactions | EXP | | 6480464 | Dimethyl Sulfoxide binds to and results in increased expression of CYP2E1 protein | CTD | PMID:3337723 |
| dimethyl sulfoxide | increases expression | ISO | RGD:1345007 | 6480464 | Dimethyl Sulfoxide results in increased expression of CYP2E1 protein | CTD | PMID:8074729 |
| dimethyl sulfoxide | multiple interactions | ISO | RGD:1345007 | 6480464 | Dimethyl Sulfoxide inhibits the reaction [CYP2E1 protein promotes the reaction [pyridine results in increased expression of CYP1A1 mRNA]] | CTD | PMID:12147272 |
| dimethyl sulfoxide | multiple interactions | ISO | RGD:1345007 | 6480464 | Dimethyl Sulfoxide inhibits the reaction [Cycloheximide results in increased degradation of CYP2E1 protein] | CTD | PMID:9143349 |
| dimethyl sulfoxide | affects expression | ISO | RGD:1345007 | 6480464 | Dimethyl Sulfoxide affects the expression of CYP2E1 mRNA | CTD | PMID:12843640 |
| dimethylmercury | decreases expression | EXP | | 6480464 | dimethyl mercury results in decreased expression of CYP2E1 protein | CTD | PMID:21424224 |
| dimethylmercury | multiple interactions | EXP | | 6480464 | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP2E1 protein] | CTD | PMID:21424224 |
| dioxygen | decreases expression | ISO | RGD:1345007 | 6480464 | Oxygen deficiency results in decreased expression of CYP2E1 mRNA | CTD | PMID:19695866 |
| dipropyl disulfide | decreases activity | ISO | RGD:1345007 | 6480464 | n-propyl disulfide results in decreased activity of CYP2E1 protein | CTD | PMID:18339364 |
| disulfiram | multiple interactions | ISO | RGD:1345007 | 6480464 | Disulfiram inhibits the reaction [CYP2E1 protein results in increased oxidation of Halothane] | CTD | PMID:10805064 |
| disulfiram | multiple interactions | ISO | RGD:10451 | 6480464 | [Disulfiram results in decreased activity of CYP2E1 protein] which affects the activity of Styrene | CTD | PMID:20470765 |
| disulfiram | multiple interactions | ISO | RGD:1345007 | 6480464 | [Disulfiram results in decreased activity of CYP2E1 protein] which affects the activity of Styrene | CTD | PMID:20470765 |
| disulfiram | decreases expression | EXP | | 6480464 | Disulfiram results in decreased expression of CYP2E1 mRNA; more ... | CTD | PMID:9393675 |
| disulfiram | decreases activity | EXP | | 6480464 | Disulfiram results in decreased activity of CYP2E1 protein | CTD | PMID:9393675 |
| disulfiram | decreases activity | ISO | RGD:1345007 | 6480464 | Disulfiram results in decreased activity of CYP2E1 protein | CTD | PMID:8637342 |
| disulfiram | multiple interactions | EXP | | 6480464 | Disulfiram binds to and results in decreased activity of CYP2E1 protein | CTD | PMID:18754103 |
| dopamine | decreases activity | ISO | RGD:10451 | 6480464 | Dopamine results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| elemental selenium | multiple interactions | EXP | | 6480464 | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP2E1 protein] | CTD | PMID:21424224 |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol affects the reaction [CYP2E1 protein results in increased metabolism of Dimethylnitrosamine] | CTD | PMID:16235733 |
| ethanol | increases expression | ISO | RGD:1345007 | 6480464 | Ethanol results in increased expression of CYP2E1 mRNA | CTD | PMID:23300006 |
| ethanol | multiple interactions | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the reaction [Ethanol results in increased expression of and results in increased activity of CYP2A5 protein]; more ... | CTD | PMID:22552773 |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:15802389 more ... |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of CYP2E1 mRNA | CTD | PMID:22960445 more ... |
| ethanol | multiple interactions | EXP | | 6480464 | Ethanol results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:15946133 PMID:22960445 |
| ethanol | increases oxidation | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased oxidation of Ethanol | CTD | PMID:22552773 |
| ethanol | increases activity | EXP | | 6480464 | Ethanol results in increased activity of CYP2E1 protein | CTD | PMID:15998439 more ... |
| ethanol | multiple interactions | EXP | | 6480464 | allyl sulfide inhibits the reaction [Ethanol results in increased activity of CYP2E1 protein] | CTD | PMID:20116195 |
| ethanol | multiple interactions | ISO | RGD:10451 | 6480464 | allyl sulfide inhibits the reaction [Ethanol results in increased expression of CYP2E1 protein] | CTD | PMID:22138249 |
| ethanol | increases expression | ISO | RGD:1345007 | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:17590308 more ... |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | allyl sulfide inhibits the reaction [Ethanol results in increased expression of CYP2E1 protein] | CTD | PMID:22138249 |
| ethanol | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to Ethanol | CTD | PMID:20171022 |
| ethanol | increases expression | ISO | RGD:10451 | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:11515535 more ... |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | [Ethanol co-treated with CYP2E1 protein] results in increased abundance of Reactive Oxygen Species; more ... | CTD | PMID:22222162 |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 protein promotes the reaction [Ethanol results in increased expression of GCLC mRNA] | CTD | PMID:19133322 |
| ethanol | multiple interactions | EXP | | 6480464 | Plant Extracts inhibits the reaction [Ethanol results in increased activity of CYP2E1 protein] | CTD | PMID:22525864 |
| ethanol | increases activity | EXP | | 6480464 | Ethanol results in increased activity of CYP2E1 protein | CTD | PMID:15998439 more ... |
| ethanol | increases expression | ISO | RGD:10451 | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:11515535 more ... |
| ethanol | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Ethanol | CTD | PMID:10573527 more ... |
| ethanol | multiple interactions | ISO | RGD:10451 | 6480464 | [AQP4 protein affects the susceptibility to Ethanol] which affects the expression of CYP2E1 mRNA | CTD | PMID:20615459 |
| ethanol | increases response to substance | EXP | | 6480464 | CYP2E1 protein results in increased susceptibility to Ethanol | CTD | PMID:21130154 |
| ethanol | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of Ethanol | CTD | PMID:11147839 more ... |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:3113478 more ... |
| ethanol | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of Ethanol | CTD | PMID:11147839 more ... |
| ethanol | increases expression | ISO | RGD:10451 | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:19951287 more ... |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] | CTD | PMID:8074729 PMID:8531136 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:7601153 more ... |
| ethanol | increases expression | ISO | RGD:10451 | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:19951287 more ... |
| ethanol | multiple interactions | ISO | RGD:10451 | 6480464 | SOD1 protein affects the reaction [Ethanol results in increased expression of CYP2E1 protein] | CTD | PMID:19951287 |
| ethanol | increases expression | ISO | RGD:10451 | 6480464 | Ethanol results in increased expression of CYP2E1 | CTD | PMID:16317704 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:3113478 more ... |
| ethanol | increases activity | EXP | | 6480464 | Ethanol results in increased activity of CYP2E1 protein | CTD | PMID:21704112 PMID:15998439 |
| ethanol | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Ethanol | CTD | PMID:18845238 more ... |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:3113478 more ... |
| ethanol | increases activity | EXP | | 6480464 | Ethanol results in increased activity of CYP2E1 protein | CTD | PMID:15998439 PMID:21704112 |
| ethanol | increases expression | ISO | RGD:10451 | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:20118189 more ... |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:7562599 more ... |
| ethanol | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of Ethanol | CTD | PMID:7562599 more ... |
| ethanol | increases expression | ISO | RGD:10451 | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:15920153 more ... |
| ethanol | increases expression | ISO | RGD:1345007 | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:3782137 more ... |
| ethanol | increases activity | ISO | RGD:1345007 | 6480464 | Ethanol results in increased activity of CYP2E1 protein | CTD | PMID:11212141 PMID:8074729 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:7601153 more ... |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of CYP2E1 mRNA | CTD | PMID:8130774 PMID:7562599 |
| ethanol | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of Ethanol | CTD | PMID:7562599 more ... |
| ethanol | increases expression | ISO | RGD:10451 | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:11515535 more ... |
| ethanol | increases activity | ISO | RGD:10451 | 6480464 | Ethanol results in increased activity of CYP2E1 protein | CTD | PMID:15920153 PMID:10667633 |
| ethanol | increases expression | ISO | RGD:1345007 | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:17590308 more ... |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:15802389 PMID:18845238 |
| ethanol | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Ethanol | CTD | PMID:10826103 more ... |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 protein results in increased metabolism of Ethanol] which results in increased abundance of Acetaldehyde; more ... | CTD | PMID:18845238 |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 protein results in increased metabolism of Ethanol] which results in decreased abundance of Glutathione | CTD | PMID:10573527 |
| ethanol | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Ethanol | CTD | PMID:10826103 more ... |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | [Arachidonic Acid co-treated with ferric nitrilotriacetate co-treated with Ethanol] results in increased expression of CYP2E1 protein; more ... | CTD | PMID:17034788 |
| ethanol | multiple interactions | EXP | | 6480464 | S-Adenosylmethionine inhibits the reaction [CYP2E1 protein results in increased metabolism of Ethanol] | CTD | PMID:15763544 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:7601153 more ... |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of CYP2E1 mRNA | CTD | PMID:7562599 PMID:8130774 |
| ethanol | multiple interactions | EXP | | 6480464 | Ethanol results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:15946133 |
| ethanol | multiple interactions | EXP | | 6480464 | [Ethanol results in increased activity of CYP2E1 protein] which results in increased metabolism of vinyl fluoride | CTD | PMID:9073601 |
| ethanol | increases activity | EXP | | 6480464 | Ethanol results in increased activity of CYP2E1 protein | CTD | PMID:15998439 |
| ethanol | multiple interactions | EXP | | 6480464 | Ethanol promotes the reaction [CYP2E1 protein results in increased oxidation of Toluene] | CTD | PMID:1994898 |
| ethanol | multiple interactions | EXP | | 6480464 | Ethanol promotes the reaction [CYP2E1 protein results in increased metabolism of 4-nitrophenol]; more ... | CTD | PMID:7601153 |
| ethanol | multiple interactions | EXP | | 6480464 | Ethanol inhibits the reaction [CYP2E1 protein results in increased reduction of tirapazamine] | CTD | PMID:7710944 |
| ethanol | multiple interactions | EXP | | 6480464 | [Ethanol co-treated with nitrosobenzylmethylamine] results in increased expression of CYP2E1 protein | CTD | PMID:16704527 |
| ethanol | affects activity | EXP | | 6480464 | Ethanol affects the activity of CYP2E1 protein | CTD | PMID:17533807 |
| ethanol | multiple interactions | EXP | | 6480464 | Ethanol binds to and results in increased expression of CYP2E1 protein | CTD | PMID:3337723 |
| ethanol | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of Ethanol | CTD | PMID:15763544 more ... |
| ethanol | multiple interactions | EXP | | 6480464 | [CYP2E1 protein results in increased metabolism of Ethanol] which results in increased chemical synthesis of Acetaldehyde; more ... | CTD | PMID:7562599 |
| ethanol | multiple interactions | EXP | | 6480464 | Carnitine promotes the reaction [Ethanol results in increased expression of CYP2E1 protein] | CTD | PMID:8130774 |
| ethanol | multiple interactions | ISO | RGD:10451 | 6480464 | [Urethane co-treated with Ethanol] results in increased activity of CYP2E1 protein | CTD | PMID:15582191 |
| ethanol | increases expression | ISO | RGD:10451 | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:20118189 more ... |
| ethanol | multiple interactions | ISO | RGD:10451 | 6480464 | Zinc Sulfate inhibits the reaction [Ethanol results in increased expression of CYP2E1 protein]; more ... | CTD | PMID:15920153 |
| ethanol | increases activity | ISO | RGD:10451 | 6480464 | Ethanol results in increased activity of CYP2E1 protein | CTD | PMID:10667633 PMID:15920153 |
| ethanol | multiple interactions | ISO | RGD:10451 | 6480464 | [Betaine co-treated with Choline co-treated with Folic Acid co-treated with Methionine co-treated with Vitamin B 12 co-treated with Zinc Sulfate] inhibits the reaction [Ethanol results in increased expression of CYP2E1 protein] | CTD | PMID:20118189 |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | Tetradecanoylphorbol Acetate promotes the reaction [CYP2E1 protein results in increased susceptibility to Ethanol] | CTD | PMID:8798623 |
| ethanol | increases expression | ISO | RGD:1345007 | 6480464 | Ethanol results in increased expression of CYP2E1 protein | CTD | PMID:17590308 more ... |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:18845238 PMID:15802389 |
| ethanol | increases activity | ISO | RGD:1345007 | 6480464 | Ethanol results in increased activity of CYP2E1 protein | CTD | PMID:8074729 PMID:11212141 |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] | CTD | PMID:8531136 PMID:8074729 |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol promotes the reaction [CYP2E1 protein results in increased oxidation of aniline]; more ... | CTD | PMID:8074729 |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol inhibits the reaction [Cycloheximide results in increased degradation of CYP2E1 protein] | CTD | PMID:9143349 |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol affects the reaction [CYP2E1 protein results in increased susceptibility to Acetaminophen] | CTD | PMID:11212141 |
| ethanol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol inhibits the reaction [Carbon Tetrachloride inhibits the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol]] | CTD | PMID:8531136 |
| ethanol | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased susceptibility to Ethanol | CTD | PMID:8798623 |
| ethene | increases metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased metabolism of ethylene | CTD | PMID:21785163 |
| ethene | decreases activity | EXP | | 6480464 | ethylene results in decreased activity of CYP2E1 protein | CTD | PMID:15141094 |
| ethene | multiple interactions | ISO | RGD:10451 | 6480464 | [CYP2E1 protein results in increased metabolism of ethylene] which results in increased abundance of Ethylene Oxide | CTD | PMID:21785163 |
| ethosuximide | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of Ethosuximide | CTD | PMID:1438522 |
| ethylbenzene | multiple interactions | EXP | | 6480464 | ethylbenzene results in increased expression of and results in increased activity of CYP2E1 protein; more ... | CTD | PMID:11884239 |
| ethylbenzene | increases expression | EXP | | 6480464 | ethylbenzene results in increased expression of CYP2E1 protein | CTD | PMID:1417939 |
| ethylbenzene | increases expression | EXP | | 6480464 | ethylbenzene results in increased expression of CYP2E1 mRNA | CTD | PMID:11884239 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:1345007 | 6480464 | Egtazic Acid inhibits the reaction [Cycloheximide results in increased degradation of CYP2E1 protein] | CTD | PMID:9143349 |
| ethylenediaminetetraacetic acid | multiple interactions | ISO | RGD:1345007 | 6480464 | Edetic Acid inhibits the reaction [Cycloheximide results in increased degradation of CYP2E1 protein] | CTD | PMID:9143349 |
| eugenol | multiple interactions | EXP | | 6480464 | Eugenol inhibits the reaction [Thioacetamide results in increased expression of CYP2E1 protein] | CTD | PMID:20036707 |
| eugenol | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 protein co-treated with Copper] results in increased activity of Eugenol | CTD | PMID:15576237 |
| farnesol | increases activity | EXP | | 6480464 | Farnesol results in increased activity of CYP2E1 protein | CTD | PMID:15840382 |
| felbamate | decreases expression | EXP | | 6480464 | felbamate results in decreased expression of CYP2E1 mRNA | CTD | PMID:17381134 |
| fenofibrate | increases expression | EXP | | 6480464 | Fenofibrate results in increased expression of CYP2E1 mRNA | CTD | PMID:19118567 |
| fluoranthene | increases expression | ISO | RGD:1345007 | 6480464 | fluoranthene results in increased expression of CYP2E1 mRNA | CTD | PMID:16269432 |
| fluoroethene | multiple interactions | ISO | RGD:1345007 | 6480464 | [fomepizole results in decreased activity of CYP2E1 protein] which results in decreased metabolism of vinyl fluoride | CTD | PMID:9073601 |
| fluoroethene | multiple interactions | EXP | | 6480464 | [Ethanol results in increased activity of CYP2E1 protein] which results in increased metabolism of vinyl fluoride; more ... | CTD | PMID:9073601 |
| fluoroethene | multiple interactions | ISO | RGD:10451 | 6480464 | [fomepizole results in decreased activity of CYP2E1 protein] which results in decreased uptake of vinyl fluoride | CTD | PMID:9073601 |
| fluoroethene | affects oxidation | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the oxidation of vinyl fluoride | CTD | PMID:9073601 |
| fluphenazine | decreases activity | ISO | RGD:1345007 | 6480464 | Fluphenazine results in decreased activity of CYP2E1 protein | CTD | PMID:15135088 |
| folic acid | multiple interactions | ISO | RGD:10451 | 6480464 | [Betaine co-treated with Choline co-treated with Folic Acid co-treated with Methionine co-treated with Vitamin B 12 co-treated with Zinc Sulfate] inhibits the reaction [Ethanol results in increased expression of CYP2E1 protein] | CTD | PMID:20118189 |
| fomepizole | multiple interactions | ISO | RGD:1345007 | 6480464 | fomepizole inhibits the reaction [Carbon Tetrachloride results in increased degradation of CYP2E1 protein]; more ... | CTD | PMID:8531136 |
| fomepizole | increases expression | EXP | | 6480464 | fomepizole results in increased expression of CYP2E1 protein | CTD | PMID:3782137 PMID:3113478 |
| fomepizole | increases expression | EXP | | 6480464 | fomepizole results in increased expression of CYP2E1 protein | CTD | PMID:3113478 PMID:3782137 |
| fomepizole | increases activity | EXP | | 6480464 | fomepizole results in increased activity of CYP2E1 protein | CTD | PMID:3782137 |
| fomepizole | multiple interactions | ISO | RGD:10451 | 6480464 | [fomepizole results in decreased activity of CYP2E1 protein] which results in decreased uptake of vinyl fluoride | CTD | PMID:9073601 |
| fomepizole | multiple interactions | EXP | | 6480464 | fomepizole promotes the reaction [CYP2E1 protein results in increased metabolism of methylformamide] | CTD | PMID:1538706 |
| fomepizole | multiple interactions | ISO | RGD:1345007 | 6480464 | [fomepizole results in decreased activity of CYP2E1 protein] which results in decreased metabolism of vinyl fluoride | CTD | PMID:9073601 |
| fomepizole | multiple interactions | EXP | | 6480464 | [fomepizole results in decreased activity of CYP2E1 protein] which results in decreased uptake of vinyl fluoride | CTD | PMID:9073601 |
| fomepizole | increases expression | ISO | RGD:1345007 | 6480464 | fomepizole results in increased expression of CYP2E1 protein | CTD | PMID:8074729 |
| fomepizole | multiple interactions | ISO | RGD:1345007 | 6480464 | fomepizole inhibits the reaction [CYP2E1 protein affects the metabolism of 2,6-xylidine metabolite] | CTD | PMID:11409937 |
| fomepizole | multiple interactions | ISO | RGD:1345007 | 6480464 | fomepizole inhibits the reaction [Cycloheximide results in increased degradation of CYP2E1 protein] | CTD | PMID:9143349 |
| fomepizole | multiple interactions | ISO | RGD:1345007 | 6480464 | fomepizole inhibits the reaction [[CYP2E1 protein results in increased metabolism of Ethanol] which results in increased abundance of Reactive Oxygen Species] | CTD | PMID:18845238 |
| fumaraldehyde | multiple interactions | EXP | | 6480464 | 1-phenylimidazole inhibits the reaction [[[[CYP2E1 protein results in increased oxidation of furan] which results in increased chemical synthesis of malealdehyde] which co-treated with Glutathione] results in increased glutathionylation of malealdehyde] | CTD | PMID:21842885 |
| fumonisin B1 | decreases expression | ISO | RGD:10451 | 6480464 | fumonisin B1 results in decreased expression of CYP2E1 mRNA | CTD | PMID:16221962 |
| furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of CYP2E1 mRNA | CTD | PMID:15120968 |
| furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of CYP2E1 protein | CTD | PMID:20124500 |
| furan | multiple interactions | EXP | | 6480464 | [[[CYP2E1 protein results in increased oxidation of furan] which results in increased chemical synthesis of malealdehyde] which co-treated with Glutathione] results in increased glutathionylation of malealdehyde; more ... | CTD | PMID:21842885 |
| gabapentin | decreases expression | EXP | | 6480464 | gabapentin results in decreased expression of CYP2E1 mRNA | CTD | PMID:17381134 |
| gadolinium trichloride | multiple interactions | EXP | | 6480464 | gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP2E1 mRNA]; more ... | CTD | PMID:18202523 |
| gamma-hexachlorocyclohexane | increases activity | EXP | | 6480464 | Lindane results in increased activity of CYP2E1 protein | CTD | PMID:14631868 PMID:12842176 |
| gamma-hexachlorocyclohexane | decreases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in decreased susceptibility to Lindane | CTD | PMID:21458603 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of CYP2E1 protein | CTD | PMID:12842176 more ... |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of CYP2E1 mRNA | CTD | PMID:17919674 PMID:17984293 |
| gamma-hexachlorocyclohexane | decreases expression | ISO | RGD:1345007 | 6480464 | Lindane results in decreased expression of CYP2E1 mRNA | CTD | PMID:20035023 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of CYP2E1 mRNA | CTD | PMID:17984293 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of CYP2E1 protein | CTD | PMID:14631868 PMID:12842176 |
| gamma-hexachlorocyclohexane | increases activity | EXP | | 6480464 | Lindane results in increased activity of CYP2E1 protein | CTD | PMID:12842176 PMID:14631868 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of CYP2E1 protein | CTD | PMID:12842176 PMID:14631868 |
| glutathione | multiple interactions | ISO | RGD:1345007 | 6480464 | Glutathione inhibits the reaction [CYP2E1 protein results in increased susceptibility to Styrene] | CTD | PMID:16872732 |
| glutathione | multiple interactions | EXP | | 6480464 | [[[CYP2E1 protein results in increased oxidation of furan] which results in increased chemical synthesis of malealdehyde] which co-treated with Glutathione] results in increased glutathionylation of malealdehyde; more ... | CTD | PMID:21842885 |
| glutathione | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 protein results in increased metabolism of Ethanol] which results in decreased abundance of Glutathione | CTD | PMID:10573527 |
| glycerol | multiple interactions | ISO | RGD:1345007 | 6480464 | Glycerol inhibits the reaction [Cycloheximide results in increased degradation of CYP2E1 protein] | CTD | PMID:9143349 |
| glycine betaine | multiple interactions | ISO | RGD:10451 | 6480464 | [Betaine co-treated with Choline co-treated with Folic Acid co-treated with Methionine co-treated with Vitamin B 12 co-treated with Zinc Sulfate] inhibits the reaction [Ethanol results in increased expression of CYP2E1 protein] | CTD | PMID:20118189 |
| glycyrrhetinate | multiple interactions | EXP | | 6480464 | [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP2E1 protein | CTD | PMID:21800547 |
| glycyrrhetinic acid | multiple interactions | EXP | | 6480464 | [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP2E1 protein | CTD | PMID:21800547 |
| halothane | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of Halothane | CTD | PMID:10805064 |
| halothane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Halothane | CTD | PMID:12464242 PMID:11684365 |
| halothane | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Halothane | CTD | PMID:9103523 |
| halothane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Halothane | CTD | PMID:11684365 PMID:12464242 |
| halothane | increases response to substance | EXP | | 6480464 | CYP2E1 protein results in increased susceptibility to Halothane | CTD | PMID:12803597 |
| halothane | multiple interactions | ISO | RGD:1345007 | 6480464 | Disulfiram inhibits the reaction [CYP2E1 protein results in increased oxidation of Halothane] | CTD | PMID:10805064 |
| hesperetin | multiple interactions | EXP | | 6480464 | hesperetin inhibits the reaction [1,2-Dimethylhydrazine results in increased activity of CYP2E1 protein] | CTD | PMID:19497424 |
| hexachlorobenzene | decreases expression | EXP | | 6480464 | Hexachlorobenzene results in decreased expression of CYP2E1 mRNA | CTD | PMID:15159207 |
| hexachlorobenzene | increases expression | EXP | | 6480464 | Hexachlorobenzene results in increased expression of CYP2E1 protein | CTD | PMID:10696772 |
| hexane | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to n-hexane | CTD | PMID:16484137 |
| hexane | increases metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased metabolism of n-hexane | CTD | PMID:11201664 |
| hexane | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of n-hexane | CTD | PMID:16484137 |
| hydrazine | increases activity | EXP | | 6480464 | hydrazine results in increased activity of CYP2E1 protein | CTD | PMID:15132840 |
| indomethacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of CYP2E1 mRNA | CTD | PMID:16771604 |
| isatin | increases expression | ISO | RGD:1345007 | 6480464 | Isatin results in increased expression of CYP2E1 mRNA | CTD | PMID:15056799 |
| isoniazide | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to Isoniazid | CTD | PMID:12668988 |
| isoniazide | increases activity | EXP | | 6480464 | Isoniazid results in increased activity of CYP2E1 protein | CTD | PMID:12458634 more ... |
| isoniazide | increases activity | EXP | | 6480464 | Isoniazid results in increased activity of CYP2E1 protein | CTD | PMID:12458634 more ... |
| isoniazide | multiple interactions | ISO | RGD:10451 | 6480464 | Berberine inhibits the reaction [Isoniazid results in increased expression of CYP2E1 mRNA] | CTD | PMID:22342832 |
| isoniazide | increases expression | ISO | RGD:10451 | 6480464 | Isoniazid results in increased expression of CYP2E1 mRNA | CTD | PMID:22342832 |
| isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of CYP2E1 protein | CTD | PMID:3113478 more ... |
| isoniazide | increases activity | EXP | | 6480464 | Isoniazid results in increased activity of CYP2E1 protein | CTD | PMID:15132840 more ... |
| isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of CYP2E1 protein | CTD | PMID:15205388 more ... |
| isoniazide | multiple interactions | EXP | | 6480464 | Tiopronin inhibits the reaction [Isoniazid results in increased activity of CYP2E1 protein] | CTD | PMID:19683030 |
| isoniazide | multiple interactions | EXP | | 6480464 | [Isoniazid results in increased expression of CYP2E1] which results in increased metabolism of Acetaminophen | CTD | PMID:20566340 |
| isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of CYP2E1 | CTD | PMID:20566340 |
| isoniazide | increases activity | EXP | | 6480464 | Isoniazid results in increased activity of CYP2E1 protein | CTD | PMID:15132840 more ... |
| isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of CYP2E1 protein | CTD | PMID:3113478 more ... |
| isoniazide | increases activity | EXP | | 6480464 | Isoniazid results in increased activity of CYP2E1 protein | CTD | PMID:15205388 more ... |
| isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of CYP2E1 protein | CTD | PMID:15205388 more ... |
| isoniazide | increases activity | EXP | | 6480464 | Isoniazid results in increased activity of CYP2E1 protein | CTD | PMID:15132840 more ... |
| isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of CYP2E1 protein | CTD | PMID:9065729 more ... |
| isoniazide | increases activity | EXP | | 6480464 | Isoniazid results in increased activity of CYP2E1 protein | CTD | PMID:9129171 more ... |
| isoniazide | multiple interactions | EXP | | 6480464 | Thiram inhibits the reaction [Isoniazid results in increased activity of CYP2E1 protein] | CTD | PMID:12458634 |
| isoniazide | multiple interactions | EXP | | 6480464 | Rifampin inhibits the reaction [Isoniazid results in increased expression of CYP2E1 protein] | CTD | PMID:15132840 |
| isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of CYP2E1 protein | CTD | PMID:15763544 more ... |
| isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of CYP2E1 mRNA | CTD | PMID:11752103 |
| isoniazide | multiple interactions | EXP | | 6480464 | Isoniazid results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:18754103 |
| isoniazide | multiple interactions | EXP | | 6480464 | [Isoniazid results in increased activity of CYP2E1 protein] which results in increased metabolism of 4-dichlorobenzene | CTD | PMID:9051121 |
| isoniazide | increases activity | EXP | | 6480464 | Isoniazid results in increased activity of CYP2E1 protein | CTD | PMID:9051121 more ... |
| isoniazide | multiple interactions | EXP | | 6480464 | Isoniazid inhibits the reaction [CYP2E1 protein results in increased reduction of tirapazamine] | CTD | PMID:7710944 |
| isoniazide | increases expression | ISO | RGD:1345007 | 6480464 | Isoniazid results in increased expression of CYP2E1 protein | CTD | PMID:8074729 |
| isoniazide | multiple interactions | EXP | | 6480464 | 2-(allylthio)pyrazine inhibits the reaction [Isoniazid results in increased expression of CYP2E1 protein] | CTD | PMID:9065729 |
| isoniazide | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Isoniazid | CTD | PMID:17950035 |
| isoniazide | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene SNP affects the susceptibility to Isoniazid | CTD | PMID:20485159 |
| isoprenaline | affects expression | EXP | | 6480464 | Isoproterenol affects the expression of CYP2E1 mRNA | CTD | PMID:18725507 |
| ivermectin | decreases activity | ISO | RGD:10451 | 6480464 | Ivermectin results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of CYP2E1 protein | CTD | PMID:16076768 |
| kojic acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2E1 mRNA | CTD | PMID:18544905 |
| L-ascorbic acid | decreases activity | ISO | RGD:1345007 | 6480464 | Ascorbic Acid results in decreased activity of CYP2E1 protein | CTD | PMID:17512695 |
| L-methionine | multiple interactions | ISO | RGD:10451 | 6480464 | [Betaine co-treated with Choline co-treated with Folic Acid co-treated with Methionine co-treated with Vitamin B 12 co-treated with Zinc Sulfate] inhibits the reaction [Ethanol results in increased expression of CYP2E1 protein] | CTD | PMID:20118189 |
| L-methionine | multiple interactions | ISO | RGD:10451 | 6480464 | [Methionine deficiency co-treated with Choline deficiency] results in increased activity of CYP2E1 protein; more ... | CTD | PMID:18952117 |
| lamotrigine | increases glutathionylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased glutathionylation of lamotrigine | CTD | PMID:19961160 |
| lamotrigine | multiple interactions | ISO | RGD:1345007 | 6480464 | Ditiocarb inhibits the reaction [CYP2E1 protein results in increased glutathionylation of lamotrigine] | CTD | PMID:19961160 |
| lauric acid | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of lauric acid | CTD | PMID:12464242 |
| lithocholic acid | decreases activity | ISO | RGD:10451 | 6480464 | Lithocholic Acid results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| LY294002 | increases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CYP2E1 mRNA | CTD | PMID:11306697 |
| m-tolualdehyde | decreases activity | EXP | | 6480464 | 3-methylbenzaldehyde results in decreased activity of CYP2E1 protein | CTD | PMID:12791539 |
| m-xylene | affects activity | EXP | | 6480464 | 3-xylene affects the activity of CYP2E1 protein | CTD | PMID:15204773 PMID:8598570 |
| m-xylene | multiple interactions | ISO | RGD:1345007 | 6480464 | Ditiocarb inhibits the reaction [CYP2E1 protein results in increased metabolism of 3-xylene] | CTD | PMID:8558417 |
| m-xylene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 3-xylene | CTD | PMID:17156750 |
| m-xylene | increases hydrolysis | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydrolysis of 3-xylene | CTD | PMID:10353308 |
| m-xylene | multiple interactions | EXP | | 6480464 | 3-xylene promotes the reaction [CYP2E1 protein results in increased metabolism of Methylene Chloride] | CTD | PMID:8889796 |
| m-xylene | decreases activity | EXP | | 6480464 | 3-xylene results in decreased activity of CYP2E1 protein | CTD | PMID:12791539 |
| m-xylene | affects activity | EXP | | 6480464 | 3-xylene affects the activity of CYP2E1 protein | CTD | PMID:8598570 PMID:15204773 |
| m-xylene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 3-xylene | CTD | PMID:8558417 |
| m-xylene | increases activity | EXP | | 6480464 | 3-xylene results in increased activity of CYP2E1 protein | CTD | PMID:8889796 |
| maneb | decreases activity | EXP | | 6480464 | Maneb results in decreased activity of CYP2E1 protein | CTD | PMID:11043497 |
| maneb | increases expression | EXP | | 6480464 | Maneb results in increased expression of CYP2E1 mRNA | CTD | PMID:20888808 PMID:23159886 |
| maneb | multiple interactions | ISO | RGD:10451 | 6480464 | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased activity of CYP2E1 protein]; more ... | CTD | PMID:20964710 |
| maneb | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of and results in increased activity of CYP2E1 protein]; more ... | CTD | PMID:23159886 |
| maneb | increases expression | EXP | | 6480464 | Maneb results in increased expression of CYP2E1 mRNA; more ... | CTD | PMID:20888808 |
| maneb | increases activity | EXP | | 6480464 | Maneb results in increased activity of CYP2E1 protein | CTD | PMID:20888808 |
| maneb | multiple interactions | ISO | RGD:10451 | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of CYP2E1 mRNA | CTD | PMID:16510128 |
| mangiferin | decreases activity | EXP | | 6480464 | mangiferin results in decreased activity of CYP2E1 protein | CTD | PMID:18053976 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Benzene results in increased activity of CYP2E1 protein] | CTD | PMID:20338863 |
| melatonin | multiple interactions | ISO | RGD:10451 | 6480464 | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP2E1 mRNA]; more ... | CTD | PMID:20964710 |
| metformin | increases expression | ISO | RGD:10451 | 6480464 | Metformin results in increased expression of CYP2E1 mRNA | CTD | PMID:22342832 |
| methamphetamine | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Methamphetamine metabolite | CTD | PMID:16038959 |
| methoxsalen | decreases activity | EXP | | 6480464 | Methoxsalen results in decreased activity of CYP2E1 protein | CTD | PMID:15879494 |
| methoxsalen | decreases activity | ISO | RGD:10451 | 6480464 | Methoxsalen results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| methoxychlor | multiple interactions | EXP | | 6480464 | Methoxychlor results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:12919727 |
| methoxychlor | decreases activity | ISO | RGD:10451 | 6480464 | Methoxychlor results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| microcystin-LR | multiple interactions | ISO | RGD:10451 | 6480464 | Chlormethiazole inhibits the reaction [cyanoginosin LR results in increased expression of CYP2E1 mRNA]; more ... | CTD | PMID:21684301 |
| microcystin-LR | increases expression | ISO | RGD:10451 | 6480464 | cyanoginosin LR results in increased expression of CYP2E1 mRNA; more ... | CTD | PMID:21684301 |
| mirex | decreases expression | EXP | | 6480464 | Mirex results in decreased expression of CYP2E1 protein | CTD | PMID:3113478 |
| monocrotophos | increases expression | EXP | | 6480464 | Monocrotophos results in increased expression of CYP2E1 protein | CTD | PMID:21445290 |
| monocrotophos | multiple interactions | ISO | RGD:1345007 | 6480464 | [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP2E1 protein; more ... | CTD | PMID:22733800 |
| monocrotophos | increases expression | ISO | RGD:1345007 | 6480464 | Monocrotophos results in increased expression of CYP2E1 protein; more ... | CTD | PMID:22733800 |
| monocrotophos | increases activity | ISO | RGD:1345007 | 6480464 | Monocrotophos results in increased activity of CYP2E1 protein | CTD | PMID:22733800 |
| N,N-diethyl-m-toluamide | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of DEET | CTD | PMID:11854147 |
| N,N-dimethylformamide | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein polymorphism affects the metabolism of Dimethylformamide | CTD | PMID:11305777 |
| N,N-dimethylformamide | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Dimethylformamide | CTD | PMID:9817075 |
| N,N-dimethylformamide | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of Dimethylformamide | CTD | PMID:15772367 |
| N,N-dimethylformamide | increases expression | EXP | | 6480464 | Dimethylformamide results in increased expression of CYP2E1 protein | CTD | PMID:10547960 |
| N,N-dimethylformamide | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of Dimethylformamide | CTD | PMID:10207612 |
| N-acetyl-1,4-benzoquinone imine | multiple interactions | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased chemical synthesis of and results in increased abundance of N-acetyl-4-benzoquinoneimine | CTD | PMID:19679878 |
| N-acetyl-1,4-benzoquinone imine | increases chemical synthesis | EXP | | 6480464 | CYP2E1 results in increased chemical synthesis of N-acetyl-4-benzoquinoneimine | CTD | PMID:20566340 |
| N-acetyl-1,4-benzoquinone imine | increases chemical synthesis | ISO | RGD:1345007 | 6480464 | CYP2E1 results in increased chemical synthesis of N-acetyl-4-benzoquinoneimine | CTD | PMID:20566340 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP2E1 protein] | CTD | PMID:21424224 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP2E1 mRNA]; more ... | CTD | PMID:23159886 |
| N-methyl-4-phenylpyridinium | multiple interactions | ISO | RGD:10451 | 6480464 | [AQP4 protein affects the susceptibility to 1-Methyl-4-phenylpyridinium] which affects the expression of CYP2E1 mRNA | CTD | PMID:20615459 |
| N-methylformamide | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of methylformamide | CTD | PMID:1538706 |
| N-methylformamide | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of methylformamide | CTD | PMID:1538706 |
| N-methylformamide | multiple interactions | EXP | | 6480464 | 4-nitrophenol inhibits the reaction [CYP2E1 protein results in increased metabolism of methylformamide]; more ... | CTD | PMID:1538706 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1345007 | 6480464 | CYB5 protein promotes the reaction [CYP2E1 protein results in increased activity of Diethylnitrosamine] | CTD | PMID:15728263 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of CYP2E1 mRNA | CTD | PMID:19638242 PMID:20360939 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of CYP2E1 mRNA | CTD | PMID:20360939 PMID:19638242 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2E1 mRNA | CTD | PMID:18544905 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP2E1 mRNA | CTD | PMID:20360939 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of CYP2E1 protein | CTD | PMID:16246485 |
| N-nitrosodiethylamine | increases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased susceptibility to Diethylnitrosamine | CTD | PMID:18056438 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP2E1 mRNA | CTD | PMID:14656948 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CYP2E1 protein; more ... | CTD | PMID:17393424 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Dietary Fats co-treated with Diethylnitrosamine] results in increased expression of CYP2E1 protein; more ... | CTD | PMID:19551842 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP2E1 mRNA | CTD | PMID:16158176 |
| N-nitrosodiethylamine | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased susceptibility to Diethylnitrosamine | CTD | PMID:14669323 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:10451 | 6480464 | CYP2E1 protein promotes the reaction [Diethylnitrosamine results in increased expression of CASP3 mRNA]; more ... | CTD | PMID:18056438 |
| N-nitrosodiethylamine | increases activity | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased activity of Diethylnitrosamine | CTD | PMID:15728263 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 protein co-treated with POR protein] results in increased susceptibility to Diethylnitrosamine | CTD | PMID:11035158 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to Diethylnitrosamine | CTD | PMID:11733072 |
| N-nitrosodiethylamine | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Diethylnitrosamine | CTD | PMID:2655891 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of and results in increased activity of Diethylnitrosamine | CTD | PMID:11774366 |
| N-nitrosodimethylamine | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Dimethylnitrosamine | CTD | PMID:2655891 PMID:16235733 |
| N-nitrosodimethylamine | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Dimethylnitrosamine | CTD | PMID:15242818 PMID:12464242 |
| N-nitrosodimethylamine | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Dimethylnitrosamine | CTD | PMID:16235733 PMID:2655891 |
| N-nitrosodimethylamine | decreases methylation | EXP | | 6480464 | CYP2E1 protein results in decreased methylation of Dimethylnitrosamine | CTD | PMID:3113478 PMID:8194125 |
| N-nitrosodimethylamine | decreases expression | ISO | RGD:10451 | 6480464 | Dimethylnitrosamine results in decreased expression of CYP2E1 mRNA | CTD | PMID:11356909 |
| N-nitrosodimethylamine | multiple interactions | EXP | | 6480464 | S-Adenosylmethionine inhibits the reaction [CYP2E1 protein results in increased metabolism of Dimethylnitrosamine] | CTD | PMID:15763544 |
| N-nitrosodimethylamine | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of Dimethylnitrosamine | CTD | PMID:15763544 |
| N-nitrosodimethylamine | multiple interactions | EXP | | 6480464 | allyl sulfide inhibits the reaction [CYP2E1 protein results in increased metabolism of Dimethylnitrosamine] | CTD | PMID:8117321 |
| N-nitrosodimethylamine | decreases methylation | EXP | | 6480464 | CYP2E1 protein results in decreased methylation of Dimethylnitrosamine | CTD | PMID:8194125 PMID:3113478 |
| N-nitrosodimethylamine | multiple interactions | ISO | RGD:1345007 | 6480464 | Lipopolysaccharides affects the reaction [CYP2E1 protein results in increased metabolism of Dimethylnitrosamine]; more ... | CTD | PMID:16235733 |
| N-nitrosodimethylamine | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol promotes the reaction [CYP2E1 protein results in increased oxidation of Dimethylnitrosamine] | CTD | PMID:8074729 |
| N-nitrosodimethylamine | multiple interactions | ISO | RGD:1345007 | 6480464 | Dimethylnitrosamine inhibits the reaction [Carbon Tetrachloride inhibits the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol]]; more ... | CTD | PMID:8531136 |
| N-nitrosodimethylamine | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Dimethylnitrosamine | CTD | PMID:12464242 PMID:15242818 |
| N-nitrosodimethylamine | multiple interactions | ISO | RGD:1345007 | 6480464 | diallyl sulfone inhibits the reaction [CYP2E1 protein results in decreased methylation of Dimethylnitrosamine]; more ... | CTD | PMID:11181492 |
| N-nitrosodimethylamine | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of and results in increased activity of Dimethylnitrosamine | CTD | PMID:11960914 |
| N-nitrosodimethylamine | decreases methylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in decreased methylation of Dimethylnitrosamine | CTD | PMID:11181492 |
| N-nitrosodimethylamine | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to Dimethylnitrosamine | CTD | PMID:11733072 |
| N-nitrosodimethylamine | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of and results in increased activity of Dimethylnitrosamine | CTD | PMID:11600130 |
| NADP zwitterion | multiple interactions | ISO | RGD:1345007 | 6480464 | [vinyl carbamate co-treated with NADP] inhibits the reaction [CYP2E1 protein results in decreased methylation of Dimethylnitrosamine] | CTD | PMID:11181492 |
| NADP(+) | multiple interactions | ISO | RGD:1345007 | 6480464 | [vinyl carbamate co-treated with NADP] inhibits the reaction [CYP2E1 protein results in decreased methylation of Dimethylnitrosamine] | CTD | PMID:11181492 |
| naphthalene | increases expression | ISO | RGD:1345007 | 6480464 | naphthalene results in increased expression of CYP2E1 mRNA | CTD | PMID:20500019 |
| nifedipine | decreases activity | ISO | RGD:10451 | 6480464 | Nifedipine results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| nitric oxide | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 protein results in increased metabolism of Ethanol] which results in increased abundance of Nitric Oxide | CTD | PMID:18845238 |
| nitroglycerin | increases expression | EXP | | 6480464 | Nitroglycerin results in increased expression of CYP2E1 mRNA | CTD | PMID:12102619 |
| o-xylene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 2-xylene | CTD | PMID:8558417 |
| o-xylene | multiple interactions | EXP | | 6480464 | Acetone promotes the reaction [2-xylene results in increased expression of CYP2E1 protein] | CTD | PMID:8996725 |
| o-xylene | increases expression | EXP | | 6480464 | 2-xylene results in increased expression of CYP2E1 protein | CTD | PMID:8996725 |
| o-xylene | multiple interactions | ISO | RGD:1345007 | 6480464 | Ditiocarb inhibits the reaction [CYP2E1 protein results in increased metabolism of 2-xylene] | CTD | PMID:8558417 |
| o-xylene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 2-xylene | CTD | PMID:17156750 |
| ochratoxin A | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased susceptibility to ochratoxin A | CTD | PMID:11189750 |
| oleanolic acid | multiple interactions | ISO | RGD:10451 | 6480464 | Oleanolic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of and results in increased activity of CYP2E1 protein] | CTD | PMID:10355542 |
| oleanolic acid | decreases expression | EXP | | 6480464 | Oleanolic Acid results in decreased expression of CYP2E1 mRNA | CTD | PMID:18706400 |
| oleanolic acid | decreases expression | ISO | RGD:10451 | 6480464 | Oleanolic Acid results in decreased expression of CYP2E1 mRNA | CTD | PMID:18706400 |
| omeprazole | multiple interactions | ISO | RGD:1345007 | 6480464 | Omeprazole results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:15802389 |
| orphenadrine | multiple interactions | ISO | RGD:1345007 | 6480464 | Orphenadrine inhibits the reaction [CYP2E1 protein results in increased chemical synthesis of 7-hydroxy-4-trifluoromethylcoumarin]; more ... | CTD | PMID:9241656 |
| orphenadrine | decreases activity | ISO | RGD:1345007 | 6480464 | Orphenadrine results in decreased activity of CYP2E1 protein | CTD | PMID:9241656 |
| oxirane | multiple interactions | ISO | RGD:10451 | 6480464 | [CYP2E1 protein results in increased metabolism of ethylene] which results in increased abundance of Ethylene Oxide | CTD | PMID:21785163 |
| ozone | decreases expression | ISO | RGD:10451 | 6480464 | Ozone results in decreased expression of CYP2E1 mRNA | CTD | PMID:12763052 |
| p-cresol | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 4-cresol | CTD | PMID:16174805 |
| p-xylene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of 4-xylene | CTD | PMID:8558417 |
| p-xylene | multiple interactions | ISO | RGD:1345007 | 6480464 | Ditiocarb inhibits the reaction [CYP2E1 protein results in increased metabolism of 4-xylene] | CTD | PMID:8558417 |
| p-xylene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 4-xylene | CTD | PMID:17156750 |
| paracetamol | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Acetaminophen | CTD | PMID:15576447 PMID:12464242 |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | Acetaminophen results in increased expression of and results in increased activity of CYP2E1 protein; more ... | CTD | PMID:22939915 |
| paracetamol | multiple interactions | EXP | | 6480464 | Arsenic inhibits the reaction [Acetaminophen results in increased activity of CYP2E1 protein] | CTD | PMID:19932728 |
| paracetamol | increases activity | EXP | | 6480464 | Acetaminophen results in increased activity of CYP2E1 protein | CTD | PMID:19932728 |
| paracetamol | decreases expression | ISO | RGD:10451 | 6480464 | Acetaminophen results in decreased expression of CYP2E1 protein | CTD | PMID:15576447 more ... |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased expression of CYP2E1 protein] | CTD | PMID:22683606 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CYP2E1 mRNA | CTD | PMID:17126469 PMID:21807079 |
| paracetamol | increases response to substance | EXP | | 6480464 | CYP2E1 protein results in increased susceptibility to Acetaminophen | CTD | PMID:21130154 |
| paracetamol | increases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased susceptibility to Acetaminophen | CTD | PMID:11323178 more ... |
| paracetamol | increases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased susceptibility to Acetaminophen | CTD | PMID:16557553 more ... |
| paracetamol | multiple interactions | EXP | | 6480464 | [Isoniazid results in increased expression of CYP2E1] which results in increased metabolism of Acetaminophen | CTD | PMID:20566340 |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | Taurine inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 protein] | CTD | PMID:20067817 |
| paracetamol | increases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased susceptibility to Acetaminophen | CTD | PMID:19679878 more ... |
| paracetamol | increases expression | ISO | RGD:10451 | 6480464 | Acetaminophen results in increased expression of CYP2E1 protein | CTD | PMID:19002106 PMID:20067817 |
| paracetamol | decreases expression | ISO | RGD:10451 | 6480464 | Acetaminophen results in decreased expression of CYP2E1 protein | CTD | PMID:21329376 PMID:15576447 |
| paracetamol | increases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased susceptibility to Acetaminophen | CTD | PMID:16557553 more ... |
| paracetamol | increases activity | ISO | RGD:10451 | 6480464 | Acetaminophen results in increased activity of CYP2E1 protein | CTD | PMID:19799668 PMID:20166895 |
| paracetamol | increases expression | ISO | RGD:10451 | 6480464 | Acetaminophen results in increased expression of CYP2E1 mRNA | CTD | PMID:16393943 PMID:12958197 |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased metabolism of and affects the susceptibility to Acetaminophen | CTD | PMID:11376689 |
| paracetamol | increases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased susceptibility to Acetaminophen | CTD | PMID:19679878 more ... |
| paracetamol | increases metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased metabolism of Acetaminophen | CTD | PMID:19002106 |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the metabolism of and results in decreased abundance of Acetaminophen | CTD | PMID:19679878 |
| paracetamol | increases expression | ISO | RGD:10451 | 6480464 | Acetaminophen results in increased expression of CYP2E1 protein | CTD | PMID:19002106 |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | Carnosine inhibits the reaction [Acetaminophen results in increased activity of CYP2E1 protein] | CTD | PMID:19799668 |
| paracetamol | increases expression | ISO | RGD:10451 | 6480464 | Acetaminophen results in increased expression of CYP2E1 mRNA | CTD | PMID:12958197 PMID:16393943 |
| paracetamol | affects expression | ISO | RGD:10451 | 6480464 | Acetaminophen affects the expression of CYP2E1 mRNA | CTD | PMID:17562736 |
| paracetamol | multiple interactions | ISO | RGD:1345007 | 6480464 | Ethanol affects the reaction [CYP2E1 protein results in increased susceptibility to Acetaminophen] | CTD | PMID:11212141 |
| paracetamol | increases activity | ISO | RGD:10451 | 6480464 | Acetaminophen results in increased activity of CYP2E1 protein | CTD | PMID:20166895 PMID:19799668 |
| paracetamol | decreases expression | ISO | RGD:10451 | 6480464 | Acetaminophen results in decreased expression of CYP2E1 mRNA; more ... | CTD | PMID:15576447 |
| paracetamol | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased susceptibility to Acetaminophen | CTD | PMID:11212141 |
| paracetamol | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Acetaminophen | CTD | PMID:12464242 PMID:15576447 |
| paracetamol | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of Acetaminophen | CTD | PMID:15772367 |
| paracetamol | multiple interactions | EXP | | 6480464 | Acetaminophen results in increased phosphorylation of and results in increased activity of CYP2E1 protein; more ... | CTD | PMID:11562448 |
| paracetamol | multiple interactions | EXP | | 6480464 | Choline deficiency promotes the reaction [Acetaminophen results in increased expression of CYP2E1 protein] | CTD | PMID:18798224 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CYP2E1 protein | CTD | PMID:18798224 |
| paracetamol | multiple interactions | EXP | | 6480464 | Acetaminophen results in increased expression of and results in increased activity of CYP2E1 protein | CTD | PMID:21170329 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CYP2E1 mRNA | CTD | PMID:17126469 |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | Taurine inhibits the reaction [Acetaminophen results in increased activity of CYP2E1 protein] | CTD | PMID:20166895 |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | SLC13A1 protein affects the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA] | CTD | PMID:16729303 |
| paracetamol | multiple interactions | EXP | | 6480464 | [Acetaminophen co-treated with Uranium analog] results in decreased expression of CYP2E1 mRNA; more ... | CTD | PMID:17126469 |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | PPARA protein affects the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA] | CTD | PMID:12958197 |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | KITL protein inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA] | CTD | PMID:12594235 |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | IL1A protein inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 protein] | CTD | PMID:19002106 |
| paracetamol | increases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased susceptibility to Acetaminophen | CTD | PMID:11323178 more ... |
| paracetamol | affects response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the susceptibility to Acetaminophen | CTD | PMID:19256530 |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | [Acetaminophen results in increased activity of CYP2E1 protein] inhibits the reaction [PPARA protein results in increased oxidation of Fatty Acids]; more ... | CTD | PMID:19256530 |
| paracetamol | increases activity | ISO | RGD:10451 | 6480464 | Acetaminophen results in increased activity of CYP2E1 protein | CTD | PMID:19256530 more ... |
| paracetamol | decreases expression | ISO | RGD:10451 | 6480464 | Acetaminophen results in decreased expression of CYP2E1 protein | CTD | PMID:15576447 PMID:21329376 |
| paracetamol | multiple interactions | ISO | RGD:10451 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CYP2E1 mRNA; more ... | CTD | PMID:17585979 |
| paraquat | multiple interactions | ISO | RGD:10451 | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of CYP2E1 mRNA | CTD | PMID:16510128 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of CYP2E1 mRNA | CTD | PMID:20553223 more ... |
| paraquat | multiple interactions | ISO | RGD:10451 | 6480464 | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP2E1 mRNA]; more ... | CTD | PMID:20964710 |
| paraquat | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP2E1 mRNA]; more ... | CTD | PMID:23159886 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of CYP2E1 mRNA | CTD | PMID:20553223 PMID:20888808 |
| paraquat | multiple interactions | EXP | | 6480464 | Paraquat promotes the reaction [Zinc Sulfate results in increased expression of CYP2E1 mRNA]; more ... | CTD | PMID:20553223 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of CYP2E1 mRNA; more ... | CTD | PMID:20888808 |
| paraquat | increases activity | EXP | | 6480464 | Paraquat results in increased activity of CYP2E1 protein | CTD | PMID:20888808 |
| parathion | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Parathion | CTD | PMID:12669189 |
| pentachlorobenzene | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of pentachlorobenzene | CTD | PMID:7747284 |
| pentachlorobenzene | increases expression | EXP | | 6480464 | pentachlorobenzene results in increased expression of CYP2E1 protein | CTD | PMID:10696772 |
| pentachlorobenzene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of pentachlorobenzene | CTD | PMID:7747284 |
| pentachlorophenol | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of Pentachlorophenol | CTD | PMID:7747284 |
| perfluorooctane-1-sulfonic acid | affects expression | ISO | RGD:10451 | 6480464 | perfluorooctane sulfonic acid affects the expression of CYP2E1 mRNA | CTD | PMID:19429403 |
| perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1345007 | 6480464 | perfluorooctane sulfonic acid inhibits the reaction [CYP2E1 protein results in increased oxidation of Chlorzoxazone] | CTD | PMID:21964418 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:10451 | 6480464 | perfluorooctanoic acid results in decreased expression of CYP2E1 mRNA | CTD | PMID:17681415 |
| perfluorooctanoic acid | affects expression | ISO | RGD:10451 | 6480464 | perfluorooctanoic acid affects the expression of CYP2E1 mRNA | CTD | PMID:19429403 |
| phenacetin | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of Phenacetin | CTD | PMID:15879494 |
| phenanthrene | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of and results in increased activity of phenanthrene | CTD | PMID:19766613 |
| phenanthrene | multiple interactions | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased metabolism of and results in increased activity of phenanthrene | CTD | PMID:19766613 |
| phenethyl isothiocyanate | multiple interactions | EXP | | 6480464 | phenethyl isothiocyanate inhibits the reaction [CYP2E1 protein results in increased metabolism of Carbon Tetrachloride]; more ... | CTD | PMID:7601153 |
| phenethyl isothiocyanate | decreases expression | EXP | | 6480464 | phenethyl isothiocyanate results in decreased expression of CYP2E1 protein | CTD | PMID:7601153 |
| phenethyl isothiocyanate | multiple interactions | EXP | | 6480464 | phenethyl isothiocyanate inhibits the reaction [[CYP2E1 protein results in increased metabolism of Ethanol] which results in increased chemical synthesis of Acetaldehyde]; more ... | CTD | PMID:7562599 |
| phenobarbital | multiple interactions | EXP | | 6480464 | Choline deficiency promotes the reaction [Phenobarbital results in increased expression of CYP2E1 protein] | CTD | PMID:18798224 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CYP2E1 mRNA | CTD | PMID:17381134 PMID:15596064 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of CYP2E1 protein | CTD | PMID:18798224 |
| phenobarbital | increases activity | EXP | | 6480464 | Phenobarbital results in increased activity of CYP2E1 protein | CTD | PMID:15490126 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CYP2E1 mRNA | CTD | PMID:15596064 PMID:17381134 |
| phenol | increases metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased metabolism of Phenol | CTD | PMID:11701230 |
| phenytoin | multiple interactions | ISO | RGD:1345007 | 6480464 | NOC 18 inhibits the reaction [Phenytoin results in increased expression of CYP2E1 mRNA] | CTD | PMID:18206661 |
| phenytoin | decreases expression | EXP | | 6480464 | Phenytoin results in decreased expression of CYP2E1 mRNA | CTD | PMID:17381134 |
| phenytoin | increases expression | ISO | RGD:1345007 | 6480464 | Phenytoin results in increased expression of CYP2E1 protein; more ... | CTD | PMID:18206661 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1345007 | 6480464 | Cycloheximide inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol]] | CTD | PMID:9143349 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1345007 | 6480464 | Tetradecanoylphorbol Acetate promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] | CTD | PMID:8531136 PMID:9143349 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1345007 | 6480464 | Tetradecanoylphorbol Acetate promotes the reaction [CYP2E1 protein results in increased susceptibility to Ethanol] | CTD | PMID:8798623 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1345007 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CYP2E1 protein | CTD | PMID:8798623 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1345007 | 6480464 | Tetradecanoylphorbol Acetate promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] | CTD | PMID:9143349 PMID:8531136 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1345007 | 6480464 | Tetradecanoylphorbol Acetate inhibits the reaction [Cycloheximide inhibits the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol]] | CTD | PMID:8531136 |
| phthalaldehyde | decreases expression | ISO | RGD:10451 | 6480464 | o-Phthalaldehyde results in decreased expression of CYP2E1 mRNA | CTD | PMID:20112102 |
| primaquine | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Primaquine | CTD | PMID:19616568 |
| primaquine | multiple interactions | ISO | RGD:1345007 | 6480464 | [CYP2E1 protein results in increased expression of HBG2 protein] which affects the susceptibility to Primaquine | CTD | PMID:19616568 |
| progesterone | affects expression | ISO | RGD:10451 | 6480464 | Progesterone affects the expression of CYP2E1 mRNA | CTD | PMID:17251523 |
| progesterone | multiple interactions | EXP | | 6480464 | Progesterone promotes the reaction [Benzene results in decreased activity of CYP2E1 protein] | CTD | PMID:18407866 |
| prop-2-yn-1-ol | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of propargyl alcohol | CTD | PMID:11306107 |
| propan-2-ol | multiple interactions | EXP | | 6480464 | 2-Propanol binds to and results in increased expression of CYP2E1 protein | CTD | PMID:3337723 |
| propan-2-ol | multiple interactions | EXP | | 6480464 | 2-Propanol inhibits the reaction [CYP2E1 protein results in increased reduction of tirapazamine] | CTD | PMID:7710944 |
| propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of CYP2E1 protein | CTD | PMID:7986207 |
| psoralen | decreases expression | ISO | RGD:10451 | 6480464 | Ficusin results in decreased expression of CYP2E1 protein | CTD | PMID:22173200 |
| purpurin | decreases activity | ISO | RGD:1345007 | 6480464 | 1,2,4-trihydroxy-9,10-anthracenedione results in decreased activity of CYP2E1 protein | CTD | PMID:12379470 |
| purpurogallin | multiple interactions | EXP | | 6480464 | purpurogallin inhibits the reaction [CYP2E1 protein results in increased reduction of tirapazamine] | CTD | PMID:7710944 |
| pyridine | multiple interactions | ISO | RGD:1345007 | 6480464 | Dimethyl Sulfoxide inhibits the reaction [CYP2E1 protein promotes the reaction [pyridine results in increased expression of CYP1A1 mRNA]] | CTD | PMID:12147272 |
| pyridine | increases activity | EXP | | 6480464 | pyridine results in increased activity of CYP2E1 protein | CTD | PMID:11181506 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP2E1 protein | CTD | PMID:10215695 more ... |
| pyridine | increases activity | EXP | | 6480464 | pyridine results in increased activity of CYP2E1 protein | CTD | PMID:11181506 more ... |
| pyridine | increases activity | EXP | | 6480464 | pyridine results in increased activity of CYP2E1 protein | CTD | PMID:8246169 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP2E1 protein | CTD | PMID:1968335 more ... |
| pyridine | increases activity | EXP | | 6480464 | pyridine results in increased activity of CYP2E1 protein | CTD | PMID:1610360 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP2E1 protein | CTD | PMID:1379807 more ... |
| pyridine | increases activity | EXP | | 6480464 | pyridine results in increased activity of CYP2E1 protein | CTD | PMID:9618253 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP2E1 protein | CTD | PMID:12919724 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP2E1 protein | CTD | PMID:1610360 more ... |
| pyridine | increases activity | EXP | | 6480464 | pyridine results in increased activity of CYP2E1 protein | CTD | PMID:9618253 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP2E1 protein | CTD | PMID:12919724 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP2E1 mRNA | CTD | PMID:1379807 PMID:2241968 |
| pyridine | increases activity | EXP | | 6480464 | pyridine results in increased activity of CYP2E1 protein | CTD | PMID:8246169 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP2E1 protein | CTD | PMID:1968335 more ... |
| pyridine | increases activity | EXP | | 6480464 | pyridine results in increased activity of CYP2E1 protein | CTD | PMID:1968335 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP2E1 mRNA | CTD | PMID:2241968 PMID:1379807 |
| pyridine | multiple interactions | EXP | | 6480464 | pyridine promotes the reaction [ciprofibrate results in increased expression of CYP2E1 protein] | CTD | PMID:7587954 |
| pyridine | multiple interactions | EXP | | 6480464 | [pyridine co-treated with Methylcholanthrene] results in decreased expression of CYP2E1 mRNA; more ... | CTD | PMID:8734847 |
| pyridine | multiple interactions | EXP | | 6480464 | INS protein affects the reaction [pyridine results in increased expression of CYP2E1 protein] | CTD | PMID:10215695 |
| pyridine | multiple interactions | EXP | | 6480464 | Ditiocarb inhibits the reaction [pyridine results in increased activity of CYP2E1 protein]; more ... | CTD | PMID:9618253 |
| pyridine | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [pyridine results in increased expression of CYP2E1 protein]; more ... | CTD | PMID:1968335 |
| pyridine | increases expression | ISO | RGD:1345007 | 6480464 | pyridine results in increased expression of CYP2E1 protein | CTD | PMID:8074729 |
| pyridine | decreases activity | ISO | RGD:1345007 | 6480464 | pyridine results in decreased activity of CYP2E1 protein | CTD | PMID:12464242 |
| pyridine N-oxide | increases expression | EXP | | 6480464 | pyridine N-oxide results in increased expression of CYP2E1 protein | CTD | PMID:1379807 |
| pyrogallol | increases activity | ISO | RGD:10451 | 6480464 | Pyrogallol results in increased activity of CYP2E1 protein | CTD | PMID:18789925 |
| pyrogallol | multiple interactions | ISO | RGD:10451 | 6480464 | resveratrol inhibits the reaction [Pyrogallol results in increased activity of CYP2E1 protein]; more ... | CTD | PMID:18789925 |
| pyrogallol | increases expression | ISO | RGD:10451 | 6480464 | Pyrogallol results in increased expression of CYP2E1 mRNA | CTD | PMID:18789925 |
| quartz | decreases expression | EXP | | 6480464 | Quartz results in decreased expression of CYP2E1 mRNA | CTD | PMID:19836432 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [CYP2E1 protein results in increased reduction of tirapazamine] | CTD | PMID:7710944 |
| quercetin | decreases activity | ISO | RGD:10451 | 6480464 | Quercetin results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [INS1 protein results in decreased expression of CYP2E1 mRNA] | CTD | PMID:11306697 |
| quinacrine | multiple interactions | EXP | | 6480464 | Quinacrine binds to and results in decreased activity of CYP2E1 protein | CTD | PMID:18754103 |
| quinacrine | decreases expression | EXP | | 6480464 | Quinacrine results in decreased expression of CYP2E1 protein | CTD | PMID:18754103 |
| quinidine | decreases activity | ISO | RGD:10451 | 6480464 | Quinidine results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| quinoline | increases hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased hydroxylation of quinoline | CTD | PMID:8824525 |
| quinoline | increases hydroxylation | EXP | | 6480464 | CYP2E1 protein results in increased hydroxylation of quinoline | CTD | PMID:8824525 |
| resveratrol | increases expression | ISO | RGD:10451 | 6480464 | resveratrol results in increased expression of CYP2E1 mRNA | CTD | PMID:22610192 |
| resveratrol | decreases activity | ISO | RGD:10451 | 6480464 | resveratrol results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| resveratrol | multiple interactions | ISO | RGD:10451 | 6480464 | resveratrol inhibits the reaction [Pyrogallol results in increased activity of CYP2E1 protein]; more ... | CTD | PMID:18789925 |
| resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of CYP2E1 mRNA | CTD | PMID:15748624 |
| resveratrol | decreases activity | ISO | RGD:10451 | 6480464 | resveratrol analog results in decreased activity of CYP2E1 protein | CTD | PMID:16684708 |
| riddelliine | increases expression | EXP | | 6480464 | riddelliine results in increased expression of CYP2E1 mRNA | CTD | PMID:18047722 PMID:18047727 |
| riddelliine | increases expression | EXP | | 6480464 | riddelliine results in increased expression of CYP2E1 mRNA | CTD | PMID:18047727 PMID:18047722 |
| rifampicin | increases activity | ISO | RGD:1345007 | 6480464 | Rifampin results in increased activity of CYP2E1 protein | CTD | PMID:18071298 |
| rifampicin | multiple interactions | ISO | RGD:1345007 | 6480464 | [Rifampin co-treated with Monocrotophos] results in increased activity of CYP2E1 protein; more ... | CTD | PMID:22733800 |
| rifampicin | increases expression | ISO | RGD:1345007 | 6480464 | Rifampin results in increased expression of CYP2E1 mRNA | CTD | PMID:18071298 PMID:22733800 |
| rifampicin | increases expression | ISO | RGD:1345007 | 6480464 | Rifampin results in increased expression of CYP2E1 protein | CTD | PMID:22733800 |
| rifampicin | multiple interactions | EXP | | 6480464 | Rifampin inhibits the reaction [Isoniazid results in increased expression of CYP2E1 protein] | CTD | PMID:15132840 |
| rifampicin | increases expression | ISO | RGD:1345007 | 6480464 | Rifampin results in increased expression of CYP2E1 mRNA | CTD | PMID:18071298 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of CYP2E1 mRNA | CTD | PMID:21515302 |
| S-adenosyl-L-methionine | decreases activity | EXP | | 6480464 | S-Adenosylmethionine results in decreased activity of CYP2E1 protein | CTD | PMID:15763544 |
| S-adenosyl-L-methionine | multiple interactions | ISO | RGD:10451 | 6480464 | S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased expression of CYP2E1 protein] | CTD | PMID:22683606 |
| S-adenosyl-L-methionine | multiple interactions | EXP | | 6480464 | S-Adenosylmethionine inhibits the reaction [CYP2E1 protein results in increased metabolism of 4-nitrophenol]; more ... | CTD | PMID:15763544 |
| S-adenosyl-L-methionine | multiple interactions | ISO | RGD:10451 | 6480464 | S-Adenosylmethionine promotes the reaction [Carbon Tetrachloride results in decreased expression of and results in decreased activity of CYP2E1 protein] | CTD | PMID:15983038 |
| S-adenosyl-L-methionine | decreases activity | ISO | RGD:1345007 | 6480464 | S-Adenosylmethionine results in decreased activity of CYP2E1 protein | CTD | PMID:15763544 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased susceptibility to Buthionine Sulfoximine | CTD | PMID:12086689 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:1345007 | 6480464 | Zinc Sulfate inhibits the reaction [CYP2E1 results in increased susceptibility to Buthionine Sulfoximine] | CTD | PMID:12566070 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:1345007 | 6480464 | Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin promotes the reaction [CYP2E1 protein results in increased susceptibility to Buthionine Sulfoximine] | CTD | PMID:12086689 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 results in increased susceptibility to Buthionine Sulfoximine | CTD | PMID:12566070 |
| selenium atom | multiple interactions | EXP | | 6480464 | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP2E1 protein] | CTD | PMID:21424224 |
| sevoflurane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of sevoflurane | CTD | PMID:7879937 |
| staurosporine | multiple interactions | EXP | | 6480464 | Staurosporine inhibits the reaction [INS1 protein results in decreased expression of CYP2E1 mRNA] | CTD | PMID:11306697 |
| staurosporine | increases expression | EXP | | 6480464 | Staurosporine results in increased expression of CYP2E1 mRNA | CTD | PMID:11306697 |
| streptozocin | decreases expression | ISO | RGD:10451 | 6480464 | Streptozocin results in decreased expression of CYP2E1 protein | CTD | PMID:12700423 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of CYP2E1 protein | CTD | PMID:14693714 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of CYP2E1 mRNA | CTD | PMID:11752103 |
| styrene | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to Styrene | CTD | PMID:14751678 PMID:12604177 |
| styrene | increases expression | ISO | RGD:1345007 | 6480464 | Styrene results in increased expression of CYP2E1 mRNA | CTD | PMID:21030303 |
| styrene | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 results in increased metabolism of and results in increased susceptibility to Styrene; more ... | CTD | PMID:22366341 |
| styrene | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the metabolism of Styrene | CTD | PMID:12893075 PMID:20117323 |
| styrene | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to Styrene | CTD | PMID:12604177 more ... |
| styrene | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to Styrene | CTD | PMID:12604177 PMID:14751678 |
| styrene | multiple interactions | ISO | RGD:10451 | 6480464 | [Disulfiram results in decreased activity of CYP2E1 protein] which affects the activity of Styrene | CTD | PMID:20470765 |
| styrene | multiple interactions | ISO | RGD:1345007 | 6480464 | [Disulfiram results in decreased activity of CYP2E1 protein] which affects the activity of Styrene | CTD | PMID:20470765 |
| styrene | increases expression | EXP | | 6480464 | Styrene results in increased expression of CYP2E1 mRNA; more ... | CTD | PMID:16418063 PMID:18202523 |
| styrene | increases expression | EXP | | 6480464 | Styrene results in increased expression of CYP2E1 protein; more ... | CTD | PMID:18202523 PMID:16418063 |
| styrene | multiple interactions | EXP | | 6480464 | gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP2E1 mRNA]; more ... | CTD | PMID:18202523 |
| styrene | multiple interactions | ISO | RGD:10451 | 6480464 | [Ditiocarb co-treated with CYP2E1 gene mutant form] results in decreased metabolism of Styrene | CTD | PMID:12746132 |
| styrene | increases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased susceptibility to Styrene | CTD | PMID:15110085 |
| styrene | affects metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the metabolism of Styrene | CTD | PMID:12746132 |
| styrene | multiple interactions | ISO | RGD:1345007 | 6480464 | Smoke inhibits the reaction [CYP2E1 protein affects the metabolism of Styrene] | CTD | PMID:16125881 |
| styrene | multiple interactions | ISO | RGD:1345007 | 6480464 | GSTM1 protein affects the reaction [CYP2E1 protein affects the metabolism of Styrene] | CTD | PMID:12464798 |
| styrene | multiple interactions | ISO | RGD:1345007 | 6480464 | Glutathione inhibits the reaction [CYP2E1 protein results in increased susceptibility to Styrene]; more ... | CTD | PMID:16872732 |
| styrene | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased susceptibility to Styrene | CTD | PMID:16872732 |
| styrene | affects oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the oxidation of Styrene | CTD | PMID:16872732 |
| styrene | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism results in increased susceptibility to Styrene | CTD | PMID:11535253 |
| styrene | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the metabolism of Styrene | CTD | PMID:12893075 |
| styrene | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Styrene | CTD | PMID:12464798 |
| styrene | decreases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism results in decreased metabolism of Styrene | CTD | PMID:16125881 |
| styrene oxide | increases chemical synthesis | ISO | RGD:1345007 | 6480464 | CYP2E1 results in increased chemical synthesis of styrene oxide; more ... | CTD | PMID:22366341 |
| Sudan I | increases oxidation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased oxidation of 1-phenylazo-2-naphthol | CTD | PMID:17159775 |
| sulforaphane | multiple interactions | ISO | RGD:10451 | 6480464 | sulforafan inhibits the reaction [cyanoginosin LR results in increased expression of CYP2E1 protein]; more ... | CTD | PMID:21684301 |
| tamoxifen | decreases activity | ISO | RGD:10451 | 6480464 | Tamoxifen results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| taurine | multiple interactions | ISO | RGD:10451 | 6480464 | Taurine inhibits the reaction [Acetaminophen results in increased activity of CYP2E1 protein] | CTD | PMID:20166895 |
| taurine | multiple interactions | ISO | RGD:10451 | 6480464 | Taurine inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 protein] | CTD | PMID:20067817 |
| testosterone | increases expression | ISO | RGD:10451 | 6480464 | Testosterone results in increased expression of CYP2E1 mRNA | CTD | PMID:20403060 |
| testosterone | increases expression | ISO | RGD:10451 | 6480464 | Testosterone results in increased expression of CYP2E1 protein | CTD | PMID:7839370 |
| tetrachloroethene | increases response to substance | EXP | | 6480464 | CYP2E1 protein results in increased susceptibility to Tetrachloroethylene | CTD | PMID:17433522 |
| tetrachloromethane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Carbon Tetrachloride | CTD | PMID:8531136 more ... |
| tetrachloromethane | decreases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 protein | CTD | PMID:12466116 more ... |
| tetrachloromethane | decreases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 mRNA | CTD | PMID:12759355 more ... |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CYP2E1 protein | CTD | PMID:21224420 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CYP2E1 mRNA | CTD | PMID:11903743 PMID:21224420 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | Alkaloids inhibits the reaction [Carbon Tetrachloride results in increased expression of CYP2E1 mRNA]; more ... | CTD | PMID:21224420 |
| tetrachloromethane | decreases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 protein | CTD | PMID:12466116 more ... |
| tetrachloromethane | decreases activity | EXP | | 6480464 | Carbon Tetrachloride results in decreased activity of CYP2E1 protein | CTD | PMID:14706259 more ... |
| tetrachloromethane | multiple interactions | ISO | RGD:10451 | 6480464 | ginsan promotes the reaction [Carbon Tetrachloride results in decreased expression of CYP2E1 protein] | CTD | PMID:19913046 |
| tetrachloromethane | decreases activity | EXP | | 6480464 | Carbon Tetrachloride results in decreased activity of CYP2E1 protein | CTD | PMID:16288784 more ... |
| tetrachloromethane | decreases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 protein | CTD | PMID:12466116 more ... |
| tetrachloromethane | decreases activity | EXP | | 6480464 | Carbon Tetrachloride results in decreased activity of CYP2E1 protein | CTD | PMID:14706259 more ... |
| tetrachloromethane | decreases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 mRNA | CTD | PMID:15962327 more ... |
| tetrachloromethane | decreases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 mRNA | CTD | PMID:12759355 more ... |
| tetrachloromethane | decreases activity | EXP | | 6480464 | Carbon Tetrachloride results in decreased activity of CYP2E1 protein | CTD | PMID:17410408 more ... |
| tetrachloromethane | decreases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 protein | CTD | PMID:15962327 more ... |
| tetrachloromethane | decreases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 mRNA | CTD | PMID:15056808 more ... |
| tetrachloromethane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Carbon Tetrachloride | CTD | PMID:18350910 more ... |
| tetrachloromethane | multiple interactions | ISO | RGD:1345007 | 6480464 | Carbon Tetrachloride inhibits the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] | CTD | PMID:9143349 PMID:8531136 |
| tetrachloromethane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Carbon Tetrachloride | CTD | PMID:15797236 more ... |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | Propolis inhibits the reaction [Carbon Tetrachloride results in decreased activity of CYP2E1 protein]; more ... | CTD | PMID:17410408 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of CYP2E1 mRNA] | CTD | PMID:11903743 |
| tetrachloromethane | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of Carbon Tetrachloride | CTD | PMID:7601153 |
| tetrachloromethane | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of Carbon Tetrachloride | CTD | PMID:15772367 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CYP2E1 mRNA | CTD | PMID:11903743 |
| tetrachloromethane | increases degradation | EXP | | 6480464 | Carbon Tetrachloride results in increased degradation of CYP2E1 protein | CTD | PMID:12679053 |
| tetrachloromethane | increases activity | EXP | | 6480464 | Carbon Tetrachloride results in increased activity of CYP2E1 protein | CTD | PMID:17710613 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 protein | CTD | PMID:17606319 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 mRNA | CTD | PMID:14706259 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | allyl sulfide inhibits the reaction [CYP2E1 protein results in increased metabolism of Carbon Tetrachloride]; more ... | CTD | PMID:7601153 |
| tetrachloromethane | decreases activity | EXP | | 6480464 | Carbon Tetrachloride results in decreased activity of CYP2E1 protein | CTD | PMID:16288784 more ... |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of CYP2E1 mRNA | CTD | PMID:17805973 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | acteoside inhibits the reaction [Carbon Tetrachloride results in increased expression of and results in increased activity of CYP2E1 protein] | CTD | PMID:14672760 |
| tetrachloromethane | affects response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the susceptibility to Carbon Tetrachloride | CTD | PMID:15962327 |
| tetrachloromethane | multiple interactions | ISO | RGD:10451 | 6480464 | NUPR1 protein affects the reaction [Carbon Tetrachloride results in decreased expression of CYP2E1 mRNA]; more ... | CTD | PMID:15962327 |
| tetrachloromethane | multiple interactions | ISO | RGD:10451 | 6480464 | CYP2E1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in decreased expression of BNIP3 mRNA]; more ... | CTD | PMID:17084009 |
| tetrachloromethane | multiple interactions | ISO | RGD:10451 | 6480464 | CDKN1A protein affects the reaction [Carbon Tetrachloride results in decreased expression of CYP2E1 mRNA] | CTD | PMID:12759355 |
| tetrachloromethane | increases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in increased expression of CYP2E1 protein | CTD | PMID:17610925 |
| tetrachloromethane | decreases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 protein | CTD | PMID:12466116 more ... |
| tetrachloromethane | multiple interactions | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in increased expression of and results in increased activity of CYP2E1 protein; more ... | CTD | PMID:10355542 |
| tetrachloromethane | decreases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 mRNA | CTD | PMID:15056808 more ... |
| tetrachloromethane | multiple interactions | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of and results in decreased activity of CYP2E1 protein; more ... | CTD | PMID:15983038 |
| tetrachloromethane | decreases activity | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased activity of CYP2E1 protein | CTD | PMID:17038628 |
| tetrachloromethane | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Carbon Tetrachloride | CTD | PMID:18350910 more ... |
| tetrachloromethane | increases activity | ISO | RGD:1345007 | 6480464 | Carbon Tetrachloride results in increased activity of CYP2E1 protein | CTD | PMID:17710613 |
| tetrachloromethane | multiple interactions | ISO | RGD:1345007 | 6480464 | Carbon Tetrachloride results in increased degradation of and results in decreased activity of CYP2E1 protein; more ... | CTD | PMID:8531136 |
| tetrachloromethane | multiple interactions | ISO | RGD:1345007 | 6480464 | Carbon Tetrachloride promotes the reaction [Cycloheximide results in increased degradation of CYP2E1 protein] | CTD | PMID:9143349 |
| tetrachloromethane | multiple interactions | ISO | RGD:1345007 | 6480464 | Carbon Tetrachloride inhibits the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] | CTD | PMID:8531136 PMID:9143349 |
| tetrachloromethane | multiple interactions | ISO | RGD:10451 | 6480464 | rossicaside B inhibits the reaction [Carbon Tetrachloride results in decreased activity of CYP2E1 protein] | CTD | PMID:19793341 |
| tetrachloromethane | decreases activity | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased activity of CYP2E1 protein | CTD | PMID:17038628 PMID:19793341 |
| tetrachloromethane | decreases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 protein | CTD | PMID:16445600 more ... |
| tetrachloromethane | decreases expression | ISO | RGD:10451 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP2E1 mRNA | CTD | PMID:15056808 more ... |
| tetracycline | multiple interactions | ISO | RGD:10451 | 6480464 | bicyclol inhibits the reaction [Tetracycline results in decreased expression of CYP2E1 mRNA] | CTD | PMID:19427351 |
| tetracycline | decreases expression | ISO | RGD:10451 | 6480464 | Tetracycline results in decreased expression of CYP2E1 mRNA | CTD | PMID:19427351 |
| thallium | increases response to substance | EXP | | 6480464 | CYP2E1 results in increased susceptibility to Thallium | CTD | PMID:20549620 |
| theobromine | multiple interactions | ISO | RGD:1345007 | 6480464 | 4-nitrophenol inhibits the reaction [CYP2E1 protein results in increased metabolism of Theobromine]; more ... | CTD | PMID:10215755 |
| theobromine | increases chemical synthesis | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased chemical synthesis of Theobromine | CTD | PMID:1302044 |
| theobromine | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Theobromine | CTD | PMID:10215755 |
| theophylline | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Theophylline | CTD | PMID:15948934 |
| theophylline | increases chemical synthesis | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased chemical synthesis of Theophylline | CTD | PMID:1302044 |
| theophylline | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Theophylline | CTD | PMID:15948934 PMID:16841220 |
| theophylline | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Theophylline | CTD | PMID:16841220 PMID:15948934 |
| theophylline | affects hydroxylation | ISO | RGD:1345007 | 6480464 | CYP2E1 promoter SNP affects the hydroxylation of Theophylline | CTD | PMID:16841220 |
| theophylline | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of Theophylline | CTD | PMID:15985363 |
| thioacetamide | multiple interactions | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the reaction [Thioacetamide results in increased expression of IL6 mRNA]; more ... | CTD | PMID:18374380 |
| thioacetamide | multiple interactions | EXP | | 6480464 | Eugenol inhibits the reaction [Thioacetamide results in increased expression of CYP2E1 protein] | CTD | PMID:20036707 |
| thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CYP2E1 protein | CTD | PMID:20036707 |
| thioacetamide | increases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased susceptibility to Thioacetamide | CTD | PMID:18374380 |
| thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of CYP2E1 mRNA | CTD | PMID:16297948 |
| thioridazine | decreases activity | ISO | RGD:1345007 | 6480464 | Thioridazine results in decreased activity of CYP2E1 protein | CTD | PMID:15135088 |
| thiram | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of Thiram | CTD | PMID:12458634 |
| thiram | multiple interactions | EXP | | 6480464 | Thiram inhibits the reaction [Isoniazid results in increased activity of CYP2E1 protein] | CTD | PMID:12458634 |
| toluene | affects response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism affects the susceptibility to Toluene | CTD | PMID:17292523 |
| toluene | multiple interactions | ISO | RGD:10451 | 6480464 | [Toluene co-treated with Benzene] results in increased activity of CYP2E1 protein | CTD | PMID:18455711 |
| toluene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Toluene | CTD | PMID:12464242 more ... |
| toluene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein alternative form results in increased metabolism of Toluene | CTD | PMID:20033806 |
| toluene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Toluene | CTD | PMID:12464242 more ... |
| toluene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Toluene | CTD | PMID:18350910 more ... |
| toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of CYP2E1 protein | CTD | PMID:8996725 PMID:12919724 |
| toluene | increases activity | EXP | | 6480464 | Toluene results in increased activity of CYP2E1 protein | CTD | PMID:8889796 PMID:12919724 |
| toluene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Toluene | CTD | PMID:12464242 more ... |
| toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of CYP2E1 protein | CTD | PMID:12919724 PMID:8996725 |
| toluene | multiple interactions | EXP | | 6480464 | Toluene promotes the reaction [CYP2E1 protein results in increased metabolism of Methylene Chloride] | CTD | PMID:8889796 |
| toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of CYP2E1 mRNA | CTD | PMID:12919724 |
| toluene | increases activity | EXP | | 6480464 | Toluene results in increased activity of CYP2E1 protein | CTD | PMID:12919724 PMID:8889796 |
| toluene | multiple interactions | EXP | | 6480464 | Methylcholanthrene promotes the reaction [CYP2E1 protein results in increased oxidation of Toluene]; more ... | CTD | PMID:1994898 |
| toluene | increases oxidation | EXP | | 6480464 | CYP2E1 protein results in increased oxidation of Toluene | CTD | PMID:1994898 |
| toluene | multiple interactions | EXP | | 6480464 | Acetone promotes the reaction [Toluene results in increased expression of CYP2E1 protein] | CTD | PMID:8996725 |
| toluene | increases expression | ISO | RGD:1345007 | 6480464 | Toluene results in increased expression of CYP2E1 mRNA | CTD | PMID:16581535 |
| toluene | multiple interactions | ISO | RGD:1345007 | 6480464 | Ditiocarb inhibits the reaction [CYP2E1 protein results in increased metabolism of Toluene] | CTD | PMID:8558417 |
| toluene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Toluene | CTD | PMID:8558417 more ... |
| trans-1,2-dichloroethene | multiple interactions | ISO | RGD:10451 | 6480464 | 1,2-dichloroethylene inhibits the reaction [CYP2E1 protein results in increased oxidation of 1,3-butadiene] | CTD | PMID:10828257 |
| trans-1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:15205388 more ... |
| trans-1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:9344893 more ... |
| trans-1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:20127315 more ... |
| trans-1,2-dichloroethene | multiple interactions | EXP | | 6480464 | 1,2-dichloroethylene inhibits the reaction [CYP2E1 protein affects the metabolism of Trichloroethylene]; more ... | CTD | PMID:7871537 |
| trans-1,2-dichloroethene | multiple interactions | EXP | | 6480464 | 1,2-dichloroethylene inhibits the reaction [Acetone results in increased activity of CYP2E1 protein] | CTD | PMID:9851676 |
| trans-1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:9671540 more ... |
| trans-1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:9671540 more ... |
| trans-1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:20127315 more ... |
| trans-1,2-dichloroethene | decreases expression | EXP | | 6480464 | 1,2-dichloroethylene results in decreased expression of CYP2E1 protein | CTD | PMID:9671540 |
| trans-1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP2E1 protein | CTD | PMID:15205388 more ... |
| trans-resveratrol | increases expression | ISO | RGD:10451 | 6480464 | resveratrol results in increased expression of CYP2E1 mRNA | CTD | PMID:22610192 |
| trans-resveratrol | decreases activity | ISO | RGD:10451 | 6480464 | resveratrol results in decreased activity of CYP2E1 protein | CTD | PMID:18420780 |
| trans-resveratrol | multiple interactions | ISO | RGD:10451 | 6480464 | resveratrol inhibits the reaction [Pyrogallol results in increased activity of CYP2E1 protein]; more ... | CTD | PMID:18789925 |
| trans-resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of CYP2E1 mRNA | CTD | PMID:15748624 |
| trans-resveratrol | decreases activity | ISO | RGD:10451 | 6480464 | resveratrol analog results in decreased activity of CYP2E1 protein | CTD | PMID:16684708 |
| trichloroethene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Trichloroethylene | CTD | PMID:18350910 PMID:10841534 |
| trichloroethene | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of Trichloroethylene | CTD | PMID:17710613 PMID:7871537 |
| trichloroethene | increases metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in increased metabolism of Trichloroethylene | CTD | PMID:10841534 PMID:18350910 |
| trichloroethene | increases metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased metabolism of Trichloroethylene | CTD | PMID:10774820 PMID:18565563 |
| trichloroethene | increases response to substance | ISO | RGD:1345007 | 6480464 | CYP2E1 gene polymorphism results in increased susceptibility to Trichloroethylene | CTD | PMID:19351467 |
| trichloroethene | increases activity | EXP | | 6480464 | Trichloroethylene results in increased activity of CYP2E1 protein | CTD | PMID:17710613 |
| trichloroethene | multiple interactions | EXP | | 6480464 | Trichloroethylene inhibits the reaction [Acetone results in increased activity of CYP2E1 protein] | CTD | PMID:9851676 |
| trichloroethene | increases response to substance | EXP | | 6480464 | CYP2E1 protein results in increased susceptibility to Trichloroethylene | CTD | PMID:17433522 |
| trichloroethene | affects metabolic processing | EXP | | 6480464 | CYP2E1 protein affects the metabolism of Trichloroethylene | CTD | PMID:7871537 PMID:17710613 |
| trichloroethene | increases metabolic processing | EXP | | 6480464 | CYP2E1 protein results in increased metabolism of Trichloroethylene | CTD | PMID:18249509 |
| trichloroethene | multiple interactions | EXP | | 6480464 | 1,2-dichloroethylene inhibits the reaction [CYP2E1 protein affects the metabolism of Trichloroethylene] | CTD | PMID:7871537 |
| trichloroethene | increases expression | ISO | RGD:10451 | 6480464 | Trichloroethylene results in increased expression of CYP2E1 protein | CTD | PMID:10753203 |
| trichloroethene | multiple interactions | ISO | RGD:10451 | 6480464 | [diallyl disulfide results in decreased expression of CYP2E1 protein] which results in decreased metabolism of and results in decreased susceptibility to Trichloroethylene | CTD | PMID:10774820 |
| trichloroethene | increases metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased metabolism of Trichloroethylene | CTD | PMID:18565563 PMID:10774820 |
| trichloroethene | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of Trichloroethylene | CTD | PMID:17710613 |
| trichloroethene | increases activity | ISO | RGD:1345007 | 6480464 | Trichloroethylene results in increased activity of CYP2E1 protein | CTD | PMID:17710613 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CYP2E1 mRNA | CTD | PMID:21515302 |
| uranium atom | multiple interactions | EXP | | 6480464 | [Acetaminophen co-treated with Uranium analog] results in decreased expression of CYP2E1 mRNA; more ... | CTD | PMID:17126469 |
| urethane | multiple interactions | ISO | RGD:10451 | 6480464 | 1-aminobenzotriazole inhibits the reaction [CYP2E1 protein affects the metabolism of Urethane] | CTD | PMID:12704224 |
| urethane | affects metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the metabolism of Urethane | CTD | PMID:12704224 more ... |
| urethane | affects metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the metabolism of Urethane | CTD | PMID:15879495 more ... |
| urethane | affects metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the metabolism of Urethane | CTD | PMID:17979661 more ... |
| urethane | multiple interactions | ISO | RGD:10451 | 6480464 | [Urethane co-treated with Ethanol] results in increased activity of CYP2E1 protein | CTD | PMID:15582191 |
| urethane | increases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 protein results in increased susceptibility to Urethane | CTD | PMID:15790490 |
| urethane | affects oxidation | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the oxidation of Urethane | CTD | PMID:20205516 |
| urethane | affects metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the metabolism of Urethane | CTD | PMID:12704224 more ... |
| urethane | affects hydroxylation | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the hydroxylation of Urethane | CTD | PMID:15879495 |
| urethane | decreases response to substance | ISO | RGD:10451 | 6480464 | CYP2E1 gene mutant form results in decreased susceptibility to Urethane | CTD | PMID:17093202 |
| urethane | decreases metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 gene mutant form results in decreased metabolism of Urethane | CTD | PMID:12704224 |
| urethane | multiple interactions | ISO | RGD:10451 | 6480464 | CYP2E1 gene mutant form inhibits the reaction [Urethane affects the expression of MKI67 protein] | CTD | PMID:15790490 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in decreased expression of and results in decreased activity of CYP2E1 protein] | CTD | PMID:10453939 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CYP2E1 mRNA | CTD | PMID:17381134 |
| vanoxerine dihydrochloride | multiple interactions | ISO | RGD:1345007 | 6480464 | [Chlorzoxazone results in decreased activity of CYP2E1 protein] which results in decreased degradation of vanoxerine | CTD | PMID:11502731 |
| vanoxerine dihydrochloride | decreases degradation | ISO | RGD:1345007 | 6480464 | CYP2E1 protein results in decreased degradation of vanoxerine | CTD | PMID:11502731 |
| vinyl carbamate | affects metabolic processing | ISO | RGD:1345007 | 6480464 | CYP2E1 protein affects the metabolism of vinyl carbamate | CTD | PMID:11181492 |
| vinyl carbamate | affects oxidation | EXP | | 6480464 | CYP2E1 protein affects the oxidation of vinyl carbamate | CTD | PMID:17296623 |
| vinyl carbamate | multiple interactions | EXP | | 6480464 | diallyl sulfone inhibits the reaction [CYP2E1 protein affects the oxidation of vinyl carbamate] | CTD | PMID:17296623 |
| vinyl carbamate | decreases expression | ISO | RGD:10451 | 6480464 | vinyl carbamate results in decreased expression of CYP2E1 protein | CTD | PMID:11134547 |
| vinyl carbamate | decreases activity | ISO | RGD:10451 | 6480464 | vinyl carbamate results in decreased activity of CYP2E1 protein | CTD | PMID:11134547 |
| vinyl carbamate | multiple interactions | ISO | RGD:10451 | 6480464 | diallyl sulfone inhibits the reaction [CYP2E1 protein affects the oxidation of vinyl carbamate] | CTD | PMID:17341656 |
| vinyl carbamate | multiple interactions | ISO | RGD:10451 | 6480464 | [diallyl sulfone results in decreased activity of CYP2E1 protein] which affects the susceptibility to vinyl carbamate | CTD | PMID:20205516 |
| vinyl carbamate | affects oxidation | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the oxidation of vinyl carbamate | CTD | PMID:20205516 |
| vinyl carbamate | affects metabolic processing | ISO | RGD:10451 | 6480464 | CYP2E1 protein affects the metabolism of vinyl carbamate | CTD | PMID:11181492 |
| vinyl carbamate | multiple interactions | ISO | RGD:1345007 | 6480464 | [vinyl carbamate co-treated with NADP] inhibits the reaction [CYP2E1 protein results in decreased methylation of Dimethylnitrosamine] | CTD | PMID:11181492 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [INS1 protein results in decreased expression of CYP2E1 mRNA] | CTD | PMID:11306697 |
| zearalenone | increases expression | EXP | | 6480464 | Zearalenone results in increased expression of CYP2E1 mRNA | CTD | PMID:20607812 |
| zinc atom | multiple interactions | EXP | | 6480464 | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP2E1 protein] | CTD | PMID:21424224 |
| zinc sulfate | multiple interactions | ISO | RGD:10451 | 6480464 | [Betaine co-treated with Choline co-treated with Folic Acid co-treated with Methionine co-treated with Vitamin B 12 co-treated with Zinc Sulfate] inhibits the reaction [Ethanol results in increased expression of CYP2E1 protein] | CTD | PMID:20118189 |
| zinc sulfate | increases expression | EXP | | 6480464 | Zinc Sulfate results in increased expression of CYP2E1 mRNA | CTD | PMID:20553223 |
| zinc sulfate | multiple interactions | EXP | | 6480464 | Paraquat promotes the reaction [Zinc Sulfate results in increased expression of CYP2E1 mRNA]; more ... | CTD | PMID:20553223 |
| zinc sulfate | multiple interactions | ISO | RGD:1345007 | 6480464 | CYP2E1 results in increased susceptibility to [Arachidonic Acid co-treated with Zinc Sulfate]; more ... | CTD | PMID:12566070 |
| zinc sulfate | multiple interactions | ISO | RGD:10451 | 6480464 | Zinc Sulfate inhibits the reaction [Ethanol results in increased activity of CYP2E1 protein]; more ... | CTD | PMID:15920153 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP2E1 protein] | CTD | PMID:21424224 |